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 ABSTRACT 
 
 
Heat shock protein 70s (Hsp70s) and their DnaJ co-factors exist in all organisms 
and in all eukaryotic organelles.  These highly conserved chaperone pairs facilitate a 
large number of cellular processes.  ERdj3 was identified as a soluble, lumenal DnaJ 
family member that binds to unassembled immunoglobulin heavy chains (HC) along with 
the BiP chaperone complex in the endoplasmic reticulum of mammalian cells.  Here we 
demonstrate that ERdj3 binds directly to two unfolded substrates: immunoglobulin γHC 
and denatured firefly luciferase.  Using mutagenesis studies on ERdj3 in both in vivo and 
in vitro binding assays, we defined ERdj3’s critical amino acids in domain I that 
contribute to substrate binding and demonstrated that ERdj3 forms dimers, which are 
important for substrate binding.  We suggested that these features are conserved among 
all type I and type II DnaJ proteins.  Somewhat unexpectedly, we found that domain II, 
which is highly conserved among ERdj3 homologues but very different from domain II 
of Ydj1, was also essential for substrate binding.  Recent studies have demonstrated that 
Hsp70s can interact in vitro with some but not all DnaJ proteins from different organelles 
or even different organisms.  To better understand restrictions on Hsp70/DnaJ 
interactions, we expressed ERdj3 in both the yeast ER and cytosol.  Our data revealed 
that the ability to complement loss of the resident DnaJ proteins in either of these 
organelles was most dependent on its ability to interact with the resident Hsp70.  
Mutations in ERdj3 that affected substrate binding were unable to complement loss of 
Ydj1, arguing that substrate binding ability is also important.  Finally, previous studies 
suggested that DnaJ proteins often bind to unfolded substrates initially and recruit their 
Hsp70 partners.  DnaJ proteins stimulate the ATPase activity of its Hsp70 partner and 
induce a conformational change in the Hsp70 to stabilize its binding to substrate.  By 
some unknown mechanism the DnaJ protein is then released.  We established an in vitro 
model to examine the requirements for the release of ERdj3 from substrates and found 
that BiP promoted the release of ERdj3 only in the presence of ATP.  Mutations in ERdj3 
or BiP that disrupted their interaction interrupted the release of ERdj3.  BiP mutants that 
cannot bind to ATP or undergo a nucleotide-induced conformational change were also 
unable to release ERdj3.  These results demonstrate that a functional interaction between 
ERdj3 and BiP, including both a direct interaction and the ability to stimulate BiP’s 
ATPase activity are required to release ERdj3 from substrate.  Furthermore they suggest 
that the interaction with BiP may induce a reciprocal change in ERdj3 that triggers its 
release from substrates.  Based on similarities among DnaJs and Hsp70s, this is likely to 
be applicable to other Hsp70/DnaJ pairs. 
     iv
 TABLE OF CONTENTS 
 
 
CHAPTER 1. INTRODUCTION....................................................................................1 
 
1.1 Protein Folding.....................................................................................................1 
1.2 Molecular Chaperones..........................................................................................1 
1.2.1 Hsp70 proteins .........................................................................................2 
1.2.2 Mammalian ER Hsp70 .............................................................................3 
1.3 Hsp40/DnaJ Protein..............................................................................................3 
1.3.1 Yeast DnaJ homologues ...........................................................................8 
1.3.2 Mammalian ER DnaJ homologues...........................................................8 
1.4 Nucleotide Exchange Factors...............................................................................9 
1.5 Protein Folding in the ER...................................................................................11 
1.6 ER Quality Control and ER Stress .....................................................................12 
1.7 DnaJ Proteins as Specifiers of Hsp70 Function .................................................13 
1.8 Summary ............................................................................................................14 
 
CHAPTER 2. ERDJ3, A LUMENAL ER DNAJ HOMOLOG, BINDS DIRECTLY     
TO UNFOLODED PROTEINS IN THE MAMMALIAN ER: 
IDENTIFICATION OF CRITICAL RESIDUES…………………… ..15 
 
2.1 Introduction ........................................................................................................15 
2.2 Materials and Methods .......................................................................................16 
2.2.1 Production of ERdj3 mutants .................................................................16 
2.2.2 Cell culture, transfection and immunoprecipitation ..............................17 
2.2.3 Protein purification ................................................................................18 
2.2.4 Measurement of complex formation between ERdj3 proteins and 
denatured luciferase ...............................................................................18 
2.3 Results ................................................................................................................18 
2.3.1 Modeling ERdj3’s secondary structure..................................................18 
2.3.2 Mapping ERdj3’s substrate binding domain in vivo ..............................19 
2.3.3 Binding of ERdj3 to purified denatured luciferase in vitro....................22 
2.3.4 ERdj3 forms dimer, which is important for substrate binding ...............24 
2.4 Discussion ..........................................................................................................27 
 
CHAPTER 3. FUNCTIONAL CONSERVATION BETWEEN ERDJ3 AND YDJ1, 
DNAJ HOMOLOGUES IN THE MAMMALIAN ER AND YEAST 
CYTOPLASM........................................................................................30 
 
3.1 Introduction ........................................................................................................30 
3.2 Materials and Methods .......................................................................................31 
3.2.1 Preparation of Ydj1 and ERdj3 constructs ............................................31 
3.2.2 Expression and detection of Ydj1 in mammalian cells...........................32 
3.2.3 Protein expression, purification and ATPase assay...............................32 
3.2.4 ATPase assays ........................................................................................33 
     v
 3.2.5 Rescue of the slow growth phenotype of the Ydj1 mutant strain............33 
3.3 Results ................................................................................................................33 
3.3.1 Ydj1 expressed in the mammalian ER binds to BiP and ERdj3  
substrates................................................................................................33 
3.3.2 Overexpression of ERdj3 does not rescue the temperature-sensitive 
defect of the Δscj1Δjem1 strain ..............................................................34 
3.3.3 Overexpression of cytosolically localized ERdj3 rescues the 
temperature-sensitive defect of the hlj1Δ ydj1-151 strain......................37 
3.3.4 Mutations in ERdj3 that affect substrate binding are unable to       
rescue the slow growth phenotype of hlj1Δ ydj1-151 strain ..................37 
3.4 Discussion ..........................................................................................................40 
 
CHAPTER 4. REGULATED RELEASE OF ERDJ3 FROM UNFOLDED     
PROTEINS BY BIP ...............................................................................42 
 
4.1 Introduction ........................................................................................................42 
4.2 Materials and Methods .......................................................................................43 
4.2.1 Cell culture, transfection, and immunoprecipitation .............................43 
4.2.2 In vitro translation and heavy chain binding assay ...............................44 
4.2.3 IP western...............................................................................................44 
4.2.4 Protein purification ................................................................................45 
4.2.5 Measurement of complex formation between ERdj3 proteins and 
denatured luciferase ...............................................................................45 
4.2.6 Release of ERdj3 from luciferase ...........................................................45 
4.2.7 ATPase assay..........................................................................................46 
4.3 Results ................................................................................................................46 
4.3.1 Comparison of the effects of J domain mutations on ERdj3’s ability      
to associate with substrate both in vivo and in vitro..............................46 
4.3.2 Development of an in vitro system to detect binding and release of 
ERdj3 from substrates ............................................................................48 
4.3.3 ATP does not affect the binding of wild type ERdj3 or the QPD and 
HPN mutants to substrate in vitro..........................................................50 
4.3.4 BiP promoted the release of wild-type ERdj3 from chemically  
denatured luciferase in the presence of ATP..........................................50 
4.3.5 BiP mutants that do not interact with ERdj3 failed to promote the 
release of ERdj3 from substrate .............................................................50 
4.3.6 Wild type BiP does not release two ERdj3 mutants, QPD and HPN, 
from luciferase........................................................................................53 
4.4 Discussion ..........................................................................................................58 
 
CHAPTER 5. DISCUSSION ........................................................................................60 
 
LIST OF REFERENCES...................................................................................................67 
 
APPENDIX A.  SUPPLEMENTAL MATERIAL FOR CHAPTER 3 ............................83 
 
     vi
      vii
APPENDIX B.  SUPPLEMENTAL MATERIAL FOR CHAPTER 4 ............................87 
 
VITA……………………………………………………………………………………..90 
 
 LIST OF FIGURES 
 
 
Figure 1-1. Hsp70s’ ATPase cycle and substrate binding............................................. 4 
 
Figure 1-2. BiP’s multiple functions in ER ................................................................... 5 
 
Figure 1-3. Three types of DnaJ family members ......................................................... 7 
 
Figure 1-4. Characterization of mammalian ER DnaJ proteins................................... 10 
 
Figure 2-1. Structural comparisons of the DnaJ proteins ............................................ 20 
 
Figure 2-2. Determination of the ability of wild-type and mutant ERdj3 to bind      
HC in vivo................................................................................................ 21 
 
Figure 2-3. Both domain I and domain II of ERdj3 contribute to its ability to bind      
to D-Luc .................................................................................................... 23 
 
Figure 2-4. ERdj3 forms dimers in cells...................................................................... 25 
 
Figure 2-5. Deletion of domain III or mutation of Phe326 to aspartic acid affects 
ERdj3’s substrate binding ability.............................................................. 26 
 
Figure 3-1. Mammalian ER expressed Ydj1 interacts with both BiP and κLC........... 35 
 
Figure 3-2. ER expressed ERdj3 does not rescue the slow growth phenotype of the 
scj1jem1 strain...................................................................................... 36 
 
Figure 3-3. Cytosolic expression of ERdj3 rescues the temperature-sensitive      
growth phenotype of the hlj1∆ydj1-151 strain.......................................... 38 
 
Figure 3-4. ERdj3 substrate binding mutants cannot rescue the temperature      
sensitive growth phenotype of the hlj1∆ydj1-151 strain........................... 39 
 
Figure 4-1. ERdj3 binds to HC directly ..................................................................... 47 
 
Figure 4-2. WT and QPD ERdj3 bind to denatured luciferase similarly in vitro ........ 49 
 
Figure 4-3. WT and mutant (QPD and HPN) ERdj3 bind to D-Luc similarly and     
ATP does not affect their binding............................................................. 51 
 
Figure 4-4. BiP releases ERdj3 from D-Luc in an ATP-dependent manner ............... 52 
 
Figure 4-5. Only WT BiP releases ERdj3 from D-Luc ............................................... 54 
 
     viii
 Figure 4-6. Wild-type BiP can only release wild-type ERdj3 from D-Luc................. 55 
 
Figure 4-7. R197H BiP cannot be released from D-Luc by either wild-type ERdj3     
or the QPD mutant .................................................................................... 57 
 
Figure 5-1. Potential roles of domain II is ERdj3 structure......................................... 61 
 
Figure 5-2. Potential patterns of cytosolic ERdj3........................................................ 64 
 
Figure 5-3. Model for dissociation of ERdj3 from substrate proteins......................... 65 
 
Figure A-1. Schematic drawings of the domain structure of Ydj1, Scj1 and ERdj3….84 
 
Figure A-2. Expression of Ydj1 in mammalian ER ......................................................85 
 
Figure A-3. Expression of the various wild-type and mutant ERdj3 in yeast ...............86 
 
Figure B-1. WT/ΔJ ERdj3 do not bind to Protein A Sepharose beads by                        
themselves..................................................................................................88 
 
Figure B-2. Neither WT nor mutants BiP bind non-specifically to BSA blocked     
wells ...........................................................................................................89
     ix
      1
CHAPTER 1. INTRODUCTION 
 
 
1.1 Protein Folding 
Proteins are fundamental components of all organisms and participate in every 
process within cells.  To be functional in cells, proteins have to fold and achieve their 
correct three-dimensional structure.  The primary structure of a protein is a linear chain of 
amino acids that based on the properties of the amino acid side chains form a secondary 
structure of which the α-helix and β-sheet are the most common ones.  The amino acids 
that form the secondary structure then interact with each other and produce a completely 
folded, functional tertiary or in some cases quaternary structure. 
 
Most folded proteins have a hydrophobic core inside the molecule formed by the 
side chains of the hydrophobic residues, which stabilize the protein, and charged or polar 
residues on the surface that interact with water molecules nearby.  It is believed that the 
guiding principle of protein folding is to make the smallest number of hydrophobic side-
chains exposed to the surface (Pace et al., 1996).  Using both chemically or temperature 
denatured ribonuclease as the substrates, Christian Anfinsen showed that denatured 
ribonuclease could fold back to a functional shape by itself with the removal of 
denaturing chemicals or by lowering the temperature (Anfinsen, 1972).  He concluded 
that all of the information required to fold a protein is encoded in the protein itself and 
that the amino acid sequence determines the shape of the protein.  This discovery won 
him the Nobel Prize in Chemistry in 1972.  Anfinsen’s study was performed in vitro 
using a very dilute single protein, and folding started with a full length linear 
unstructured chain.  Compared to in vitro conditions, the in vivo folding environment is 
much more crowded with many different types of nascent proteins, and folding often 
occurs co-translationally, so that the N-terminus of the protein begins to fold while the C-
terminal portion of the protein is still being synthesized by the ribosome.  In many cases, 
parts of the protein that will ultimately interact with each other come from very distant 
regions of the linear polypeptide chain. 
 
1.2 Molecular Chaperones 
Although proteins are able to achieve their native state on their own in isolation, it 
soon became appreciated that many of the proteins synthesized in cells needed additional 
help to either promote folding or prevent misfolding.  The term “molecular chaperone” 
was first used by Ron Laskey in 1978 to describe the ability of nucleoplasmin, a nuclear 
protein, to prevent the aggregation of folded histone proteins with DNA during the 
assembly of nucleosomes (Laskey et al., 1978).  Nucleoplasmin did not bind to 
nucleosomes or DNA, but instead was found to interact with histones to cover their 
positive charges.  John Ellis extended the term in 1987 to define molecular chaperones as 
proteins that mediate the post-translational assembly of protein complexes (Ellis, 1987), 
but which are not themselves components of the final complex nor do they determine the 
final structure of a protein.  However, once folding is complete the chaperones leave their 
client protein and move on to assist the folding of another protein.  In 1988, it was 
 determined that chaperones assisting in this process are conserved in both prokaryotes 
and eukaryotes (Hemmingsen et al., 1988). 
 
There are two major families of chaperones that have been discovered: 
GroEL/GroES and Hsp70/DnaJs.  GroEL is a highly conserved and ubiquitously 
expressed bacterial protein that is required for the proper folding of many proteins.  To 
function properly, GroEL requires the assistance of the lid-like co-chaperone protein 
GroES.  Within the cell, partially folded substrate proteins bind to a hydrophobic binding 
patch on the interior rim of the open cavity of GroEL and finish folding within this space 
(Martin et al., 1993).  In eukaryotes, the mitochondrial proteins Hsp60 and Hsp10 are 
homologues of GroEL and GroES (Hartl, 1991; Tabibzadeh & Broome, 1999) and TricC 
is a cytosolic orthologue, which functions independently of a small co-chaperone 
(Frydman et al., 1992).  
 
Hsp70 is a large family of proteins that is highly conserved and homologues have 
been found in all organisms and all organelles.  Hsp70 proteins were originally named 
based on their size of ~70kDa and their induction by heat shock.  The Hsp70 proteins are 
composed of an N-terminal nucleotide binding domain and a C-terminal substrate 
binding domain.  The main function of this group of proteins is to bind in a nucleotide-
dependent manner to relatively short extended regions on polypeptide chains and prevent 
them from aggregating.  Using peptides to stimulate the ATPase activity of these 
proteins, it was discovered that peptides of ~5-10 amino acids in length that were 
relatively hydrophobic in nature were most likely to bind the Hsp70 protein (Flynn et al., 
1989; Flynn et al., 1991).  The recognition sequence was further defined using phage 
peptide display libraries (Blond-Elguindi et al., 1993; Fourie et al., 1994) or by screening 
cellulose bound peptides (Rudiger et al., 1997).  These studies revealed that peptides 
composed of four or five amino acids with hydrophobic residues in alternating positions 
were mostly likely to bind.  This was in keeping with the polypeptide chain being in an 
extended form with the hydrophobic residues pointing in the same direction (Blond-
Elguindi et al., 1993).  This idea was confirmed when a crystal structure was solved with 
a short peptide in the peptide binding domain of DnaK, the E. coli Hsp70 (Zhu et al., 
1996).  These binding sites are usually buried in the folded proteins and only available for 
the Hsp70 protein to bind when the substrate is in the unfolded form (Rudiger et al., 
1997).  Although the binding of GroEL and Hsp70 both rely on the hydrophobicity of the 
substrate, GroEL has a relatively low affinity for short peptides and prefers substrate 
peptides that have the capability to form some secondary structure such as an α-helix, 
whereas Hsp70 recognizes completely unfolded regions of the substrate (Landry et al., 
1992; Hayer-Hartl et al., 1994; Okazaki et al., 1994). 
 
1.2.1 Hsp70 proteins 
All of the Hsp70 proteins can be divided into four major domains.  An N-terminal 
domain encodes a highly conserved ~44 kD nucleotide binding domain (NBD) that can 
bind ATP or ADP.  A small flexible linker follows the NBD and links it to a ~18 kD 
substrate binding domain (SBD) that binds to unfolded polypeptides.  The C-terminal 
portion is a less conserved 10 kD lid domain, which is involved in capping the SBD.  The 
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NBD domain consists of two major lobes that form the nucleotide binding site.  The 
substrate binding domain forms a β-sandwich, whereas the 10 kD lid domain is mainly α-
helical (Zhu et al., 1996).  The SBD contains a groove that can interact with the 
hydrophobic region on the unfolded or mis-folded proteins.  All Hsp70 proteins have a 
weak ATPase activity, which is indispensable for binding to substrates.  Binding of ATP 
or ADP regulates the interaction between Hsp70 and substrate.  When the Hsp70 is in 
ATP bound form, the lid is open and allows peptides to bind to the SBD and release from 
it relatively rapidly.  With the hydrolysis of ATP to ADP, Hsp70 undergoes a 
conformational change that causes the lid close allowing the SBD to associate with 
peptides tightly.  The replacement of ADP with ATP induces another conformational 
change that reopens the lid and releases the substrate from the SBD (Munro and Pelham, 
1986; Liberek et al., 1991; Buchberger et al., 1995).  The ATPase cycle of Hsp70 is 
tightly controlled by regulators that either induce the ATPase activity (e.g. DnaJ proteins) 
or regulate nucleotide exchange (nucleotide exchange factors and nucleotide exchange 
inhibitors) (Figure 1-1).  These co-chaperones are involved in the intramolecular 
communication between the ATPase and substrate binding domains and regulate 
association between Hsp70 and substrate (Freeman et al., 1995). 
 
1.2.2 Mammalian ER Hsp70 
Immunoglobulin heavy chain binding protein (BiP), which was found to associate 
with the unassembled, non-secreted Ig heavy chain produced in pre-B lymphoid cell 
lines, was the first identified chaperone of the endoplasmic reticulum (Haas & Wabl, 
1983).  BiP interacts with various Ig assembly intermediates in plasmacytoma cells but 
not with completely assembled mature Ig molecules (H2L2) (Bole et al., 1986).  Cloning 
of the mammalian BiP gene revealed that it was a member of the Hsp70 gene family 
(Munro et al., 1986; Haas & Meo, 1988), suggesting that it was likely to play an 
important role in the folding and assembly of secretory pathway proteins.  In addition to 
its role in protein folding and assembly (Gaut & Hendershot, 1993; Simons et al., 1995; 
Lee et al., 1999; Vanhove et al., 2001), BiP contributes to ER calcium storage (Roy & 
Lee, 1995; Lievremont et al., 1997), targeting mis- or unfolded proteins to the 
proteosome for degradation (Buchberger et al., 1995; Skowronek et al.,1998; Zhang et 
al., 2001; Kabani et al., 2003; Okuda-Shimizu and Hendershot, 2007), and regulating the 
UPR signal transducers (Bertolotti et al., 2000; Molinari et al., 2002;Shen et al., 2002).  
Furthermore, during early stages of translocation, BiP contributes to the maintenance of 
the permeability barrier of the ER translocon (Hamman et al., 1998), which is necessary 
to maintain a proper ER environment when nascent chains enter the secretory pathway 
(Figure 1-2).  All of these BiP functions, except calcium storage, require its ATPase 
activity. 
 
1.3 Hsp40/DnaJ Protein 
Genetic studies isolated a number of genes in E. coli that are required for DNA 
replication of λ phage.  Two of these genes, DnaJ and DnaK, are required for both host 
cell and λ phage DNA replication (Yochem et al., 1978).  DnaJ is a ~43 kD protein that 
  
 
Figure 1-1. Hsp70s’ ATPase cycle and substrate binding 
Hsp70s alternate between ATP and ADP bound forms. Hsp70s associate and release 
substrate rapidly in ATP-bound form, whereas they bind and release substrate slowly in 
the ADP-bound form.  DnaJ proteins stimulate the ATPase activity of Hsp70 and induce 
the hydrolysis of ATP to ADP.  Nucleotide exchange factors (NEF) trigger the switch of 
ADP to ATP and reset the cycle.  Nucleotide exchange inhibitors block the replacement 
of ADP with ATP. 
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Figure 1-2. BiP’s multiple functions in ER 
BiP is involved in multiple processes in the mammalian ER including maintaining the 
permeability barrier of the ER translocon, assisting nascent polypeptide chain folding and 
assembly, targeting misfolded protein for degradation, contributing to ER calcium storage 
and sensing ER stress.  All these functions except contributing to calcium storage require 
its ATPase activity which can be regulated by ER DnaJ proteins.
 can interact with DnaK and serve to stimulate the ATPase activity of DnaK, which is 
necessary for its chaperone activity (Liberek et al., 1991).  Later studies recognized that 
many proteins possessed a domain that was very similar to the N-terminal 70 amino acids 
of DnaJ, which was named the J domain, and proteins that had this domain were called 
DnaJ proteins (Cheetham & Caplan, 1998; Walsh et al., 2004).  Like Hsp70, DnaJ 
proteins are found in all organisms and organelles, but the number of DnaJ proteins far 
exceeds the Hsp70 proteins in any given organelle.  For example, in the mammalian ER, 
6 DnaJ proteins have been identified, whereas only one Hsp70 is present.  
 
Based on their domain conservation with E. coli DnaJ, DnaJ proteins can be 
divided into three classes (Hennessy et al., 2000).  Class I DnaJ proteins have the highest 
domain homology with E. coli DnaJ and possess all four domains.  The N-terminal region 
encodes the ~70 amino acid J domain (Bardwell et al., 1986).  There is a hallmark His-
Pro-Asp (HPD) tri-peptide motif in the middle of J domain (Liberek et al., 1991; 
Cheetham et al., 1998), which plays a key role in the interaction with DnaK (Wall et al., 
1994).  A glycine/phenylalanine-rich flexible domain (G/F) follows the J domain.  The C 
terminus includes a cysteine-rich domain containing four CysXXCys motifs that form 
two Zn2+ atoms binding sites (Banecki et al., 1996; Szabo et al., 1996) and the substrate 
binding domain (Liberek et al., 1990).  The Gly/Phe region is not only the linker between 
J and C-terminal domains, but also is crucial for J domain’s interaction with Hsp70 and 
for DnaJ function.  Recently, crystallographic studies on the C-terminal fragment of 
Ydj1, a type I DnaJ protein in the yeast cytosol, revealed that the Cys-rich domain is a 
separate domain that is encoded within the linear sequence of the substrate binding 
domain (Li et al., 2003).  The two halves of the substrate binding domain fold together to 
form a substrate binding pocket (Li & Sha, 2005) (Figure 1-3).  Class II DnaJ proteins 
have an N-terminal J domain and the Gly/Phe-rich linker, but lack the Zn2+ binding 
domain.  The substrate binding domain of Sis1, a yeast cytosolic class II DnaJ protein 
was crystallized without a peptide substrate (Sha et al., 2000).  Although its amino acid 
homology it not high with the substrate binding domain of Ydj1, they both share a very 
similar tertiary structure.  Class III proteins only contain a J domain, which can occur 
anywhere in the protein.  Some class III proteins also bind to substrate, although in no 
case has the substrate binding domain been clearly defined.  For example, auxilin which 
contains a C-terminal J-domain can bind to clathrin and assists the uncoating of clathrin-
coated vesicles (Gruschus et al., 2004).  SV 40 large T-antigen contains an N-terminal J 
domain and binds to p53 directly (Peden et al., 1989; DeCaprio, 1999).  P58IPK, a 
recently identified mammalian ER DnaJ protein can interact with newly synthesized 
secretory proteins in vitro (Rutkowski et al., 2007) and possesses a C-terminus J domain 
(Melville et al., 1997).  Generally, class I and II proteins share a higher level of 
conservation in the J domain than class III proteins do.  Since they have less conserved J 
domains and lack a Gly/Phe-rich and Cys-rich regions, class III proteins may require 
higher specificity for their Hsp70 partner and substrates and only recognize a restricted 
subset of substrates. 
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Figure 1-3. Three types of DnaJ family members 
DnaJ proteins are divided into 3 subgroups, according to the domain conservation with 
E.coli DnaJ which consists of ~70 amino acid J domain (HPD motif), Gly/Phe rich 
domain, Cys-rich Zn2+ finger domain (domain II) and C-terminal domain.  Type I and II 
DnaJ proteins are similar except that type II lacks domain II.  Type III only contains J 
domain which can occur anywhere in the molecule.  Recent studies indicate that domain I 
which is bisected in type I DnaJ contains substrate binding site. 
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 1.3.1 Yeast DnaJ homologues 
There are three DnaJ proteins in the yeast ER and thirteen in the cytosol (Cheetham 
& Caplan, 1998).  Among these three ER DnaJ proteins, Scj1p is a class I DnaJ protein, 
and the other two, Sec63p and Jem1p, belong to class III.  Sec63p is a transmembrane 
protein with a J domain that faces ER lumen and cooperates with Kar2p, a yeast Hsp70, 
to translocate proteins into the ER co- and post-translationally (Rothblatt et al., 1989; 
Sadler et al., 1989; Brodsky et al., 1995; Corsi & Schekman, 1997).  Unlike Sec63p, 
which is required for cell growth, Scj1p (Schlenstedt et al., 1995) and Jem1p (Nishikawa 
& Endo, 1997) are soluble ER luminal proteins that are not essential for cell viability 
under normal growth conditions.  However, loss of both JEM1 and SCJ1 causes a slow 
growth phenotype at elevated temperatures.  Scj1p interacts with Kar2p to assist protein 
folding and assembly in the ER lumen (Schlenstedt et al., 1995).  The fact that the ΔScj1 
mutant is hypersensitive to tunicamycin and mutations that block N-linked glycosylation, 
is consistent with Scj1’s role in assisting protein folding (Silberstein et al., 1998).  Jem1p 
interacts with Kar2p to mediate nuclear membrane fusion (Nishikawa & Endo, 1997).  In 
the yeast cytosol, there are thirteen DnaJ proteins identified that form distinct 
DnaJ/Hsp70 pairs to assist in Hsp70’s various chaperone functions (Sahi & Craig, 2007).  
One of them, Ydj1, a class I DnaJ protein, binds to the cytosolic side of the ER 
membrane through its C-terminus farnesylation site and is required for cell growth 
(Caplan & Douglas, 1991).  Sis1, an essential gene that cannot be replaced by Ydj1 (Luke 
et al., 1991), belongs to the class II subgroup (Sha et al., 2000; Li et al., 2005). 
 
1.3.2 Mammalian ER DnaJ homologues 
In the mammalian ER, six DnaJ proteins have been identified and named ERdj1-6.  
All of them interact with BiP through their J domain and stimulate its ATPase activity in 
vitro.  ERdj1/Mtj1, is a transmembrane ER protein that binds the ribosome through its 
cytosolic domain and interacts with BiP through its luminal domain and is thought to 
couple translation with folding (Brightman et al., 1995; Chevalier et al., 2000; Dudek et 
al., 2002) and ERdj2/hSec63 (Skowronek et al., 1999; Tyedmers et al., 2000), the 
mammalian homologue of Sec63, is a multi-transmembrane ER proteins that belongs to 
the class III subgroup.  Both of these proteins are associated with Sec61 and Sec62 and 
act as co-chaperones of BiP to translocate nascent polypeptides into the ER.  
ERdj3/HEDJ (Yu et al., 2000; Lau et al., 2001; Meunier et al., 2002), a 43 kD ER 
lumenal soluble DnaJ protein, was first identified as a shiga toxin binding protein.  Shiga 
toxin is endocytosed from the plasma membrane and recognized by the cell as an 
unfolded protein.  As such it is transported back to the ER and then is retrotranslocated to 
the cytosol to perform its function (Sandvig et al., 1992; Johannes & Goud, 2000).  
Independently, ERdj3 was identified as a component of the chaperone complex that binds 
to free Ig heavy chains in mouse plasmacytoma lines (Meunier et al., 2002).  ERdj3 is 
induced by ER stress, up-regulated during B cell differentiation and is most highly 
expressed in secretory tissues (Shen & Hendershot, 2005; Shen & Hendershot, 2007).  
These data suggest that ERdj3 is likely to serve as a cofactor for BiP in regulating protein 
folding, preventing aggregation, or targeting proteins for degradation.  The fact that in 
ERdj3 knock out cells, the turn-over of free HC is increased argues that ERdj3 is most 
     8
 probably involved in protein folding and preventing aggregation (Shen et al., unpublished 
data).  Homologues of ERdj3 are found in all metazoans and are highly conserved.  
ERdj3 has been suggested to be the orthologue of yeast Scj1, since both are ER lumen 
proteins and have similar size.  ERdj4/Mdj1 (Prols et al., 2001; Shen et al., 2002) is a 
trans-membrane protein with its uncleaved signal peptide inserted into the ER membrane.  
The rest of the protein resides inside the ER where its J domain interacts with BiP.  Like 
ERdj3, ERdj4 has the highest expression level in secretory tissues and is induced by ER 
stress (Shen et al., 2002).  ERdj5, which contains four protein-disulfide isomerase 
domains (Cunnea et al., 2003; Hosoda et al., 2003) is a ubiquitous, abundant protein in 
the ER of cells.  Recent data suggests that it may play role in either disulfide bond 
formation or reduction in the ER (Dong et al., 2008).  ERdj6/P58IPK (Rutkowski et al., 
2007) is the most recently identified member of the ER DnaJ family of proteins and is 
induced by ER stress and facilitates protein maturation (Figure 1-4). 
 
1.4 Nucleotide Exchange Factors 
To release the substrate from Hsp70 proteins, ADP must be released and ATP 
reinserted into the nucleotide binding domain.  GrpE is a nucleotide exchange factor 
(NEF) found in bacteria, which binds to the ATPase domain of DnaK, induces the 
replacement of ADP with ATP, and triggers the release of unfolded substrates (Liberek et 
al., 1991; Szabo et al., 1994).  Mge1p, a soluble mitochondrial matrix protein in S. 
cerevisiae is a GrpE homolog, acting in concert with mitochondrial hsp70 in protein 
translocation (Laloraya et al., 1994; Westermann et al., 1995).  GrpE homologues also 
have been found in mammalian mitochondria that bind to mitochondria Hsp70 in an ADP 
dependent manner (Bolliger et al., 1994; Naylor et al., 1995; Naylor et al., 1998).  SSE1 
is the yeast homolog of mammalian NEF Hsp110 and acts as an efficient NEF for yeast 
cytosolic Hsp70 (Raviol et al., 2006).  Although GrpE homologues are not present in 
other eukaryotic organelles, a number of both positive and negative regulators of 
nucleotide exchange have been identified.  Hip binds to the ATPase domain of Hsc70 and 
stabilizes it in the ADP-bound state (Hohfeld et al., 1995; Prapapanich et al., 1996).  
BAG-1, a Bcl-2 binding anti-apoptotic factor was found to be able to promote the 
exchange of ADP to ATP in Hsp70 (Hohfeld & Jentsch, 1997; Stuart et al., 1998).  
HspBP1 enhances nucleotide exchange for Hsp70 in vitro (Raynes & Guerriero, Jr., 
1998).  Structural studies of GrpE with the ATPase domain of DnaK (Harrison et al., 
1997) and the Bag-1/Hsc70 complex (Sondermann et al., 2001) provided insights into the 
mechanism of nucleotide exchange.  Binding of the exchange factors to the ATPase 
domain of their Hsp70 triggers the release of substrate from Hsp70, which is achieved 
through the conserved conformational change in the ATPase domain of Hsp70. 
 
A genetic screen identified the first nuclear exchange factor for the yeast ER 
Hsp70, Kar2p.  SLS1 interacts directly with the ATPase domain of Kar2p and stimulates 
ATP hydrolysis by promoting ADP release in yeast Yarrowia lipolytica (Boisrame et al., 
1998; Kabani et al., 2000; Tyson & Stirling, 2000).  Per100p (Travers et al., 2000) and 
Sil1p (Tyson & Stirling, 2000) are the homologues of SLS1 in S. cerevisiae.  Using the 
ATPase domain of a BiP mutant as bait in a yeast two-hybrid screen, BAP (BiP- 
Associated Protein) was indentified as a nucleotide exchange factor for BiP in the
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Figure 1-4. Characterization of mammalian ER DnaJ proteins 
Six DnaJ proteins are identified in mammalian ER and named ERdj1-6 according the 
order they are found. 
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 mammalian in ER (Chung et al., 2002).  BAP is an ER-localized glycoprotein that shows 
the highest expression levels in secretory pathway tissues.  Although BAP releases both 
ATP and ADP from BiP in vitro,  BAP prefers the ADP-bound form of BiP (Chung et al., 
2002), which may allow BAP to drive the ATPase cycle of BiP forward.   
 
In the yeast ER, Lhs1p was shown to be able to substitute for Sil1p and to represent 
an alternative nucleotide exchange activity.  Lhs1 is a member of what has been referred 
to as the large Hsp70 family of proteins (Craven et al., 1996).  These proteins show a 
high degree of homology at their N-terminus to Hsp70 proteins but contain large C-
terminal extensions.  GRP170, a mammalian orthologue of Lhs1p, has nucleotide 
exchange activity for BiP in vitro (Dierks et al., 1996), suggesting it can be an alternative 
exchange factor for BiP.  In some mammalian cells, the function of BAP/Sil1 appears to 
be essential.  Mutations that cause the loss function of Sil1 have been identified in 
humans and cause Marinesco–Sjögren syndrome, an autosomal dominant 
neurodegenerative disease (Senderek et al., 2005; Anttonen et al., 2008).  A SIL1 knock-
out mouse or “woozy” mouse has been generated, which shows similar evidence of 
neurodegeneration (Zhao et al., 2005).  The relationship between SIL1 mutations and 
Marinesco-Sjögren syndrome indicates that dysfunction of chaperone assisted protein 
folding in the endoplasmic reticulum can cause multisystem disorders (Sondermann et 
al., 2001; Senderek et al., 2005; Anttonen et al., 2008). 
 
1.5 Protein Folding in the ER 
The endoplasmic reticulum (ER) is a membrane-enclosed organelle found in all 
eukaryotic cells.  The ER provides a specialized environment for the synthesis, folding, 
and assembly of nearly all proteins destined for secretion and cell surface expression.  
Secretory pathway and ER resident proteins are synthesized on ER membrane associated 
ribosomes in the cytosol.  A hydrophobic signal sequence (~11-20 amino acids), which 
usually occurs on the N-terminus of the nascent polypeptide chain, is required to direct it 
to the translocon and allow it to be translocated into ER (Lingappa et al., 1978).  After 
entering the ER, the signal sequence of the nascent polypeptide is often removed. 
Subsequently, glycans can be added to the nascent chain after ~14 amino acids have 
entered the lumen of the ER.  Oligosaccharyl-transferase (OST) can co-translationally 
add N-linked glycans to asparagine residues in N-X-S/T site where asparagine is 
followed by any amino acid except proline and then a serine or threonine (Whitley et al., 
1996).  The OST complex is associated with the translocon and N-linked glycosylation 
serves to monitor the folding of the nascent chain.  Nascent unfolded polypeptides are 
highly concentrated in the ER of a secretory cell.  Unlike most organelles, an unusually 
high proportion of proteins in the ER are unfolded proteins or unassembled subunits that 
will ultimately be delivered out of ER for further transport along the secretory pathway 
once they are mature.  
 
The ER environment is also unique in that it provides additional advantages and 
exerts certain restrictions to protein folding and assembly.  The ER possesses an 
oxidizing environment and contains a group of enzymes that allow and assist the 
formation of disulfide bonds between adjacent cysteine residues (Hwang et al., 1992). 
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 The intra- and inter-chain disulfide bonds serve to stabilize folded regions of the nascent 
chain and assemble subunits and can form co-translationally.  The nascent chain can fold 
co- or post-translationally inside the ER (Bergman & Kuehl, 1979; Chen et al., 1995), 
and in some cases, assembly begins when the individual chains are still being synthesized 
(Bergman & Kuehl, 1979).  However, improper intra- and inter-chain disulfide bonds can 
form, which can lead to large, insoluble protein aggregates.  Folding intermediates that 
contain improper disulfide bonds formed during synthesis must undergo isomerization to 
achieve the proper conformation.  In addition, ER sequesters high concentrations of 
calcium, which is required for many signal transduction pathways (Lee, 1987) and clearly 
impacts normal protein folding in this organelle.  The ER is also a unique environment 
for the production and storage of glycogen, steroids, and other macromolecules. 
 
1.6 ER Quality Control and ER Stress 
The ER is a crowded environment of newly synthesized, partially folded 
polypeptide chains where chaperones and folding enzymes aid and monitor the successful 
maturation of secretory pathway proteins through a process termed ER quality control. 
This tightly controlled system has set up stringent principals to ensure that only properly 
folded protein are delivered out of ER for secretion, while proteins that do not meet these 
requirements are quarantined in the ER (Hammond & Helenius, 1995; Ellgaard et al., 
1999).  Incompletely folded nascent polypeptide chains in the ER are recognized and 
bound by two major molecular chaperone families before they are allowed to leave ER 
for the secretory pathway: the Hsp70 family member (BiP), and lectin-like proteins, 
calnexin and calreticulin (Ellgaard & Helenius, 2001).  The calnexin/calreticulin 
chaperones system recognizes the monoglucosylated, N-linked glycans and unfolded 
regions on nascent glycoproteins (Sousa et al., 1992; Trombetta & Parodi, 1992; 
Hammond et al., 1994).  Cleavage of this glucose by glucosidase II (Kornfeld & 
Kornfeld, 1985) blocks the binding of calnexin/calreticulin and properly folded proteins 
are allowed to leave the ER (Trombetta & Parodi, 1992; Hebert et al., 1995).  However, 
incompletely folded or mis-folded peptides will be recognized by UDP-
glucosyltransferase (GT), an ER resident protein, which binds to unfolded regions of the 
nascent protein and adds a glucose to a nearby glycan allowing the unfolded substrate to 
reenter the cycle (Sousa et al., 1992; Hebert et al., 1995).  So this system is dependent on 
the presence of both unfolded regions and glycans.  The Hsp70 (BiP) chaperone family 
recognizes the hydrophobic residues on the unfolded region of nascent peptides (Flynn et 
al., 1991; Blond-Elguindi et al., 1993).  When N-linked glycosylation is blocked, in some 
cases BiP can recognize calnexin/calreticulin substrates (Balow et al., 1995; Zhang et al., 
1997). 
 
Unfolded or misfolded proteins that cannot bury hydrophobic regions by 
completing their folding remain associated with these chaperones and are retained in the 
ER.  Because calnexin is a resident ER integral membrane protein, its binding to 
substrates serves to retain them in this organelle.  Calreticulin and BiP are soluble 
proteins that are themselves kept in the ER due to an ER retention sequence at their C-
terminus (Munro & Pelham, 1987).  The binding of these molecular chaperones keeps 
unfolded proteins in the ER, prevents them from aggregating, and provides them with 
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 additional opportunities to achieve their correct conformation.  Proteins that ultimately 
fail to fold and assemble properly are retrotranslocated from the ER to the cytosol for 
intracellular degradation by the 26S proteasome (Werner et al., 1996; Hampton, 2002; 
Jarosch et al., 2003).  The assembly of individually synthesized protein subunits in the 
ER is also monitored and regulated by this quality control system. 
 
To deal with changes in the normal environment of ER that affect protein folding 
and lead to the accumulation of unfolded or misfolded proteins, ER chaperones and 
components of the quality control apparatus are up-regulated to bind and prevent proteins 
from aggregating, and provide them with additional opportunities to achieve their correct 
conformation.  This response is termed unfolded protein response (UPR) which helps to 
relieve ER stress.  The UPR can be induced by changing cell growth conditions (low pH, 
hypoxia, glucose deprivation, and calcium imbalances) or by some pharmacological 
reagents that affect ER protein folding (tunicamycin, thapsigargin, and DTT).  The UPR 
is regulated through the activation of three ER transmembrane stress transducers: IRE1 
(Ire1α and β), PERK (PKR-like ER kinase) and ATF6 (Ma & Hendershot, 2004).  Under 
normal conditions, BiP inactivates all three mammalian UPR transducers by binding to 
their lumenal domains.  When unfolded proteins accumulate, BiP is released from the 
lumenal domains of the transducers.  Both IRE1 and PERK dimerize or oligomerize and 
are phosphorylated in trans.  Ire1α and β contain C-terminal endoribonuclease activity 
that is activated during ER stress to splice 26 bases from the XBP-1 (X-box binding 
protein) mRNA, which causes a shift in the reading frame of the 3’ end of the mRNA to 
generate the active form of XBP-1 (sXBP-1).  sXBP-1 protein in turn binds to UPR 
elements in the promoters of an number of UPR target genes including ERdj3 (Shen & 
Hendershot, 2007), ERdj4 and EDEM ( Lee et al., 2002).  The Ire1 pathway is conserved 
between yeast and mammalian cells.  Ire1p, the yeast homolog, remodels HAC1 mRNA 
by the same mechanism (Cox & Walter, 1996).  Activated PERK phosphorylates 
translation initiation factor eIF-2α, which inhibits cap-dependent translation and therefore 
general protein synthesis to reduce the accumulation of unfolded proteins (Harding et al., 
1999).  In the case of ATF6, dissociation of BiP allows the protein to be transported to 
the Golgi, where the S1P and S2P proteases cleave the membrane-bound ATF6 (90kD), 
allows the release of its cytosolic transcription-factor domain from membrane (50kD).  
Then the active form of ATF6 is transported to nucleus where it binds and transactivates 
ER stress elements found in the promoters of ER chaperones and folding enzymes 
(Yoshida et al., 1998; Haze et al., 1999).  ATF6 also transcriptionally upregualtes XBP-1 
(Haze et al., 1999; Yoshida et al., 2000) which is regulated by Ire1 as described. 
 
1.7 DnaJ Proteins as Specifiers of Hsp70 Function 
In a given organelle, DnaJ proteins work with their Hsp70 partner to regulate 
multiple functions.  The number of DnaJ proteins usually far exceeds the number of 
Hsp70s, suggesting that an individual DnaJ may be specific for different functions of 
Hsp70.  BiP binds to unfolded or incompletely assembled proteins to assist their folding 
and assembly as well as to misfolded proteins that need to be degraded.  In addition BiP 
seals the translocon and regulates the UPR signal transducers.  Since BiP has multiple 
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 functions, it is possible that various ERdjs specify and regulate the different functions of 
BiP and perhaps even more ERdjs will be identified.  
 
Many DnaJ proteins can interact directly with unfolded substrates and prevent their 
aggregation in vitro.  Although in most cases, the substrate binding region has not been 
identified, studies on E. coli DnaJ (Banecki, 1996; Szabo, 1996) and the yeast cytosolic 
DnaJ proteins, Ydj1 (Li et al., 2003) and Sis1 (Sha et al., 2000), have mapped the peptide 
binding region to the C-terminal half of the protein.  Although Ydj1 and Sis1 belong to 
different classes of DnaJ proteins and the amino acid conservation between them is quite 
low, the overall structure was remarkably similar.  The substrate binding domain (domain 
I) of Ydj1is nearly identical to that found in Sis1, except that in the case of Ydj1, domain 
I is bisected in the linear sequence with a Cys-rich domain that folds independently and is 
named domain II.  The structure of peptide binding fragment of Ydj1(aa 102-384) was 
solved with a peptide bound to a hydrophobic face on domain I that was composed of 
residues from both the Ia sequence and the Ib sequence. 
 
1.8 Summary 
Until now, the substrate binding characteristics of mammalian DnaJ proteins have 
been poorly understood.  Since ERdj3 interacts with unassembled Ig heavy chains 
unusually stably in vivo, it provides a good model to study the interaction between a 
mammalian DnaJ protein and unfolded substrate.  In our first study, we determined 
ERdj3’s secondary structure (ProteinPredict) and modeled its tertiary structure on that of 
Ydj1.  Using a combination of deletional analysis and point mutations, we characterized 
the structural requirements for its binding to substrates by using unassembled HC in in 
vivo assays and denatured luciferase in in vitro assays (Chapter 2).   
 
Because we found that ERdj3 was structurally very similar to Ydj1, we further 
characterized the structural requirements for in vivo function, by testing the ability of 
Ydj1 to function in the mammalian ER using a transient expression system and for ERdj3 
to complement yeast that were deficient in either Scj1, the ER DnaJ protein or Ydj1, the 
cytosolic family member.  Because we found that ERdj3 could compensate the loss of 
Ydj1, this allowed us to examine the ability of various structural motifs that we 
demonstrated to be important for substrate binding (Chapter 3).  
 
Finally, although the requirements for Hsp70 binding and release have been well 
characterized, it has not been clear how DnaJ proteins are released from substrates.  
Using a series of ERdj3 and BiP mutants with denatured luciferase as the substrate, we 
determined the functional requirements for both BiP and ERdj3 that induce the release of 
ERdj3.  This allowed us to propose a general model for the release of DnaJ proteins from 
substrates (Chapter 4). 
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 CHAPTER 2. ERDJ3, A LUMENAL ER DNAJ HOMOLOG, BINDS DIRECTLY 
TO UNFOLODED PROTEINS IN THE MAMMALIAN ER: IDENTIFICATION 
OF CRITICAL RESIDUES 
 
 
2.1 Introduction 
Hsp70 proteins are a family of molecular chaperones found in all organisms and all 
organelles.  BiP is the mammalian ER Hsp70 homologue and was first identified as an 
immunoglobulin heavy chain binding protein (Haas & Wabl, 1983; Bole et al., 1986). 
Like other Hsp70s, BiP contains an N-terminal nucleotide binding domain that can 
interact with ATP or ADP (Kassenbrock & Kelly, 1989) and a C-terminal substrate 
binding domain (Hendershot et al., 1995).  The ATPase activity of Hsp70 proteins is 
essential for their ability to bind to substrates.  In the ATP-bound state, the substrate 
binding domain (SBD) is open, which results in both a fast on and off rate for interaction 
with unfolded proteins.  In the ADP-bound state, the SBD is closed and binds to 
substrates slowly but tightly (Liberek et al., 1991).  Binding of unfolded proteins to the 
SBD stimulates Hsp70’s ATPase activity and induces the hydrolysis of ATP to ADP in 
vitro (Flynn et al., 1989).  During this process, Hsp70 protein undergoes a 
conformational change, which induces closure of a lid over the SBD and stabilizes the 
interaction between Hsp70 and the substrate.  The release of ADP and rebinding of ATP 
resets the Hsp70 to the “open” form, which allows the substrate to be released and to fold 
(Munro et al., 1986; Liberek et al., 1991; Buchberger et al., 1995).  
 
The ATPase cycle of Hsp70 proteins is regulated by co-factors that either induce 
ATP hydrolysis or regulate nucleotide exchange.  DnaJ proteins interact with the ATP 
bound form of Hsp70s and induce ATP hydrolysis (Liberek et al., 1990).  To date, more 
than 100 proteins have been designated as DnaJ-like proteins due to the presence of a 
highly conserved ~70 amino acid domain that has been termed the “J domain”.  The J 
domain contains the signature His-Pro-Asp (HPD) tri-peptide motif, which plays a 
critical role in the interaction with Hsp70 (Liberek et al., 1991).  Mutation of HPD to 
either QPD or HPN abolishes the interaction between the mutant J domain and its Hsp70 
partners (Wall et al., 1994; Suh et al., 1998; Tsai et al., 2002).  DnaJ proteins can be 
divided into three subgroups according to their domain conservation with E. coli DnaJ 
(Hennessy et al., 2000).  Like E. coli DnaJ, Type I DnaJ proteins contain four domains: 
an N terminal J domain, a Gly/Phe-rich flexible linker domain, followed by a Cys-rich 
region that forms two Zn2+ binding sites (Banecki et al., 1996; Szabo et al., 1996), and a 
C terminal domain that may contain substrate binding motif (Liberek et al., 1990).  Type 
II DnaJ proteins are similar to type I proteins, except that they lack the Cys-rich region.  
Type III DnaJs possess only the J domain, which can be present anywhere in the 
molecule.  Like Hsp70s, DnaJ proteins exist in all organelles and organisms, but often far 
out number the Hsp70s present.  Type I and type II DnaJ proteins can interact directly 
with unfolded substrates and inhibit protein aggregation in vitro.  Studies on E. coli DnaJ 
(Banecki et al., 1996; Szabo et al., 1996) and the yeast cytosolic DnaJ proteins, Ydj1 (Li 
et al., 2003; Li & Sha, 2005) and Sis1 (Sha et al., 2000), have further defined the peptide 
binding region of type I and II DnaJ proteins.  Although some Type III DnaJs bind to 
substrate directly, like auxilin, which contains a C-terminal J-domain and binds to 
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 clathrin to assists in the uncoating of clathrin-coated vesicles (Gruschus et al., 2004), 
there are no structural data available for any of these family members. 
 
Six mammalian ER localized DnaJ-like proteins have been identified and named 
ERdj1-6 (Brightman et al., 1995; Skowronek et al., 1999; Yu et al., 2000; Prols et al., 
2001; Shen et al., 2002; Cunnea et al., 2003; Hosoda et al., 2003; Rutkowski et al., 
2007).  ERdj3 is a soluble, lumenal DnaJ family member that binds to unassembled 
immunoglobulin heavy chains (HC) along with the BiP chaperone complex in the ER 
(Meunier et al., 2002) and with a number of other unfolded proteins that are BiP 
substrates (Shen & Hendershot, 2005).  The demonstration that the ERdj3 J domain 
mutant (HPD→QPD), which abolished its interaction with BiP, did not affect its ability 
to bind to substrate (Shen & Hendershot, 2005) led us to hypothesize that ERdj3 might 
bind directly to unfolded substrates.  Since the interaction between ERdj3 and 
unassembled heavy chains is unusually stable in vivo, it was a particularly good model to 
investigate the structural features of ERdj3 that are important for substrate binding.  
Using secondary structure predictions and tertiary structure modeling, we found that the 
C-terminus of ERdj3 is very similar to that of Ydj1 (Li et al., 2003).  The domain I 
sequence is interrupted with a domain II, although it is much smaller and has an entirely 
different sequence than that of Ydj1.  Like domain I of Ydj1, it was found to be important 
for substrate binding.  Mutation of conserved hydrophobic residues in domain I 
significantly reduced interaction with substrates in vitro.  In addition, we demonstrated 
that ERdj3 exists as a dimer in cells and found that Phe326 plays a critical role in 
dimerization, which also affected substrate binding.  Finally, our data revealed that 
domain II was essential for association with γHC and denatured luciferase.   
 
2.2 Materials and Methods 
 
2.2.1 Production of ERdj3 mutants 
ERdj3 mutants were made using a Quick Change Site–Directed Mutagenesis PCR 
Kit (Stratagene) with wild type HA-tagged ERdj3 (3HA-DSL-ERdj3) and QE-ERdj3 
serving as the templates.  The QPD mutant was generated previously in our lab (Shen et 
al., 2005).  Other mutants were generated by PCR using the indicated primer pairs. 
 
∆J: 5’primer GGGGCGGTGATTGCCAAAGATGGTCATCAG and 3’ primer 
CTGATGACCATCTTTGGCAATCACCGCCCC 
∆G/F: 5’primer GGTGAAGAAGGATTACCTCGTCAGCAAGAC and 3’primer 
GTCTTGCTGACGAGGTAATCCTTCTTCACC 
∆Ia: 5’primer CATGTTTGGAGGAACCAAGTGCAATTGTCGGC and 3’primer 
GCCGACAATTGCACTTGGTTCCTCCAAACATG 
∆G/F∆Ia: 5’primer GGTGAAGAAGGATTAAAGTGCAATTGTCGGC and 3’primer 
GCCGACAATTGCACTTTAATCCTTCTTCACC 
∆II: 5’primer GTTAGAAACAAACCTGTGGCA-CTAGTGAATGAAGAACGAACG 
and 3’primerCGTTCGTTCTTCATTCACTAG-TGCCACAGGTTTGTTTCTAAC 
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 ∆IIGSGG:5’primerGTTAGAAACAAACCTGTGGCAGGCAGCGGGGGCCTAGTGA
ATGAAGAACGAACG and 3’primer 
CGTTCGTTCTTCATTCACTAGGCCCCCGCTGCCTGCCACAGGTTTGTTTCTAAC 
I113A: 5’primer CCAAGAGGAAGTGATGCTATTGTAGATCTAGAAGTC and 3’ 
primer GACTTCTAGATCTACAATACCATCACTTCCTCTTGG 
V132A: 5’ primer GCAGGAAATTTTGTGGAAGCAGTTAGAAACAAACCTGTGG 
and 3’ primer CCACAGGTTTGTTTCTAACTCCTTCCACAAAATTTCCTGC 
L226A: 5’ primer GTGAATGAAGAACGAACGGCGGAAGTAGAAATAGAGCCTG 
and 3’ primer CAGGCTCTATTTCTACTTCCCCCGTTCGTTCTTCATTCAC 
F241A: 5’ primer CCTGGAGATTTACGGGCCCGAATCAAAGTTGTC and 3’ primer 
GACAACTTTGATTCGGGCCCGTAAATCTCCAGG 
F326A: 5’ primer GGGCTCTTTGATAATCACTTTTGATGTGGATGCTCCAAAAGA 
ACAG and 3’ primer CTGTTCTTTTGGAGCATCCACATCAAAAGTGATTATCAAA 
GAGCCC 
F326D: 5’primer GGGCTCTTTGATAATCACTTTTGATGTGGATGATCCAAAAGA 
ACAG and 3’primer CTGTTCTTTTGGATCATCCACATCAAAAGTGATTATCAAA 
GAGCCC 
 
To generate the ∆III mutant, a PCR reaction was performed using 3HA-DSL-
ERdj3 as the template with 5’EcoRI-CGGAATTCGGACCCGGGAC and 3’NotI-
ATAAGAATGCGGCCGCCAGTGCTTGACAACTTTGATTCGG as primer pairs. 
After cutting the PCR product with EcoRI and NotI, it was ligated into the 3HA-DSL 
vector in place of the corresponding EcoRI – NotI fragment present in full length ERdj3.  
This mutant removes all of domain III as well as the remaining 30 C-terminal amino 
acids. 
 
2.2.2 Cell culture, transfection and immunoprecipitation 
COS-1 monkey kidney fibroblast cells were maintained in DMEM media 
supplemented with 10% fetal bovine serum, 2mM L-glutamine, and 1% Fungisone and 
cultured in 3% CO2 at 37 °C.  Cells were transfected with the indicated vectors using the 
Fugene 6 transfection reagent (Roche Diagnostics), and forty-eight hours post-
transfection cells were labeled with 35S Translabel (Amersham Biosciences) for 3h.  After 
washing with PBS, cells were incubated with 3,3’-dithio-bis (propionic acid N-
hydroxysuccinimide ester) (DSP), a membrane permeable cross-linking reagent as 
described previously (Meunier et al., 2002a) to stabilize the interaction of ERdj3 with HC.  
Cell lysates were prepared using an NP40 lysing buffer and immunoprecipitated with the 
indicated antisera followed by binding to Protein A Sepharose beads.  The rabbit 
polyclonal ERdj3 antibody (Shen et al., 2005) was affinity purified on recombinant 
mouse ERdj3 protein for our studies.  All the ERdj3 deletion constructs were engineered 
with an HA-epitope tag at their C terminus, which can be recognized with an anti-HA 
monoclonal antibody (a kind gift of Dr. Albert Reynolds, Vanderbilt University).  
Immunoprecipitated complexes were analyzed by SDS-PAGE under reducing conditions, 
and the signal was detected using Amplify (Amersham Bioscience) for autoradiographic 
visualization. 
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 2.2.3 Protein purification 
The expression of His-tagged wild-type and mutant ERdj3 proteins were induced in 
E. coli M15 cells with 0.1 mM isopropyl β-D-thiogalactoside (Sigma) followed by 
growth for 18 h at 18°C.  The recombinant proteins were purified on  Ni2+-agarose 
columns under non-denaturing conditions (Qiagen QIAexpress system), dialyzed in 
25mM sodium phosphate buffer (pH 7.0) containing 150mM NaCl, 0.02% Triton X-100, 
50% glycerol, and a protease inhibitor cocktail (Roche), and stored at -20°C. 
 
2.2.4 Measurement of complex formation between ERdj3 proteins and denatured 
luciferase  
Wild type or mutant ERdj3 recombinant proteins (0.5μg in 100 μl of PBS 
containing 0.05% BSA) were added to each well of a 96-well microtiter plate purchased 
from Theromo (Immulon 2HB Flat Bottom Microtiter Plate) and allowed to bind 
overnight at 4ºC.  Wells were washed three times with PBS to remove unbound ERdj3 
and blocked with 200μl PBS containing 1% BSA for 1h at room temperature.  Firefly 
luciferase was denatured in buffer containing 7M Urea, 25mM HEPES (pH 7.5), 50mM 
KCl, 5mM EDTA, 5mM MgCl2, and 5mM dithiothreitol at room temperature for 40 min 
and then diluted into PBS containing 0.05% BSA (final concentration 5 µg/ml).  100 μl 
of this solution was added to the wells containing wild type or mutant ERdj3 and allowed 
to bind for 1hr at room temperature followed by washing with PBS to remove unbound 
luciferase.  The amount of denatured luciferase that remained bound to ERdj3 was 
detected with a polyclonal anti-luciferase antiserum followed by donkey anti-rabbit Ig 
conjugated to alkaline phosphatase (Promega).  The substrate 4-Nitrophenyl phosphate 
disodium salt hexahydrate (Sigma) was added to the wells for approximately 10 min, and 
then 0.75 M NaCl was added to stop the reaction.  The plates were read on a 
spectrophotometer (BioRAD) at wavelength 405nM.  Negative controls were included 
for each plate in wells that did not contain either denatured luciferase, ERdj3, or each of 
the antibodies, but which included all the other steps of the reaction.  The amount of  D-
Luc that bind to WT ERdj3 was set as 100%, the amount of D-Luc bound to indicated 
forms of mutants were set as percentage of WT. 
 
2.3 Results 
 
2.3.1 Modeling ERdj3’s secondary structure 
We have recently demonstrated that ERdj3 can bind directly to free HC and 
denatured luciferase in vitro (Jin et al., submitted).  To begin to characterize the regions 
of ERdj3 that contribute to substrate binding, we first used a computer program 
(Predictproteins) to generate a secondary structure prediction for ERdj3 and compared it 
with those of two yeast cytosolic DnaJ proteins for which structural data are available for 
the protein binding domain, Ydj1 (type I DnaJ subgroup) and Sis1 (type II DnaJ 
subgroup) (Sha et al., 2000; Li et al., 2005).  Although the amino acid sequences of these 
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two proteins are not highly conserved, their overall secondary (Figure 2-1A) and tertiary 
structures are very similar, except that Sis1 lacks the cysteine-rich domain II, which is a 
hallmark domain of type I DnaJ proteins.  Comparison of the secondary structure 
predictions revealed that ERdj3 is likely to be more similar to Ydj1, in that it appears to 
have an additional sequence (domain II) inserted within domain I (Figure 2-1A).  
However, the sequence and size of this domain is quite different from that of Ydj1 
(Figure 2-1A & B).  The corresponding domain in Ydj1 is 65 amino acids in length, with 
8 cysteine residues that form two zinc binding centers (CXXCXG motif),   whereas the 
predicted domain in ERdj3 is only 40 amino acids in length and possesses only four 
cysteine residues that form two intradomain disulfide bonds (Shen et al., 2005; Marcus et 
al., 2007).  Using PyMol (DeLano Scientific LLC ) to model the structure of ERdj3 in 
this region, we found that domains I and III of these two molecules appeared to be almost 
identical, whereas domain II could not be modeled on the structure of Ydj1 (data not 
shown). 
 
2.3.2 Mapping ERdj3’s substrate binding domain in vivo 
Based on the crystal structures of Ydj1 and Sis1 and our ability to model ERdj3 on 
the Ydj1 structure, we defined domain boundaries for ERdj3 and referred to them as 
domain I (Ia and Ib), II and III and made corresponding deletion mutants (Figure 2-2A).  
In addition, we deleted the J domain, the Gly/Phe-rich domain alone, and the Gly/Phe-
rich domain along with domain Ia to investigate the role of each of these domains in 
substrate binding.  The HA-epitope tag that is encoded at the carboxyl terminus of each 
of these mutants ensured our ability to immunoprecipitate each of them.  For domain III, 
we removed the sequence that was predicted to form this domain, as well as the 
remaining 30 amino acids at the carboxy-terminus.  Domain Ia and Ib were deleted 
separately, even though the structural predictions suggest that they should fold together to 
form an intact domain I.  In the case of domain II, two deletion mutants were made, one 
that removed only the sequence encoding this domain (ΔII) and a second one in which 
domain II was replaced by a four amino acid flexible linker, GSGG, to increase the 
possibility that the two halves of domain I would fold correctly in the absence of domain 
II (Figure 2-2A).  Each of the ERdj3 constructs was first expressed in COS cells alone.  
SDS-PAGE analysis revealed that all of the proteins were expressed and could be 
immunoprecipitated with the anti-HA antibody (Figure 2-2C).  Importantly none of these 
proteins bound non-specifically to Protein A Sepharose beads (Figure 2-2C).  The ERdj3 
constructs were next co-expressed with HC, and an attempt was made to normalize the 
expression of the various mutants.  To determine the ability of the various ERdj3 proteins 
to associate with HC, cells were treated with DSP, which is required to stabilize ERdj3’s 
association with γHC (Meunier et al., 2002), and then co-immunoprecipitation assays 
were performed with the indicated antibodies (Figure 2-2B).  The presence of HC, BiP, 
and GRP94 in the anti-HA lanes is not meaningful, as the HC bind directly to Protein A-
Sepharose and co-precipitate these two chaperones.  When each of the lysates was 
immunoprecipitated only with Protein A beads to isolate HC, we found that wild-type 
ERdj3 was co-precipitated as expected (Figure 2-2B).  Examination of each of the 
mutants revealed that deletion of the J domain (J) actually increased the binding of this
  
 
Figure 2-1. Structural comparisons of the DnaJ proteins 
(A) Secondary structure predictions for Ydj1, Sis1, and ERdj3.  Colors represent the 
different domains: Light grey: ER targeting sequence; Grey: J domain; Bold and Italics: 
domain I; Bold and underlined: domain II, and Black: domain III. H: α helix and E: β 
sheet.  (B) Shematic of domain boundaries for Ydj1, Sis1 and ERdj3. Sis1does not 
contain cysteine-rich domain II found in Ydj1.  ERdj3 is more similar to Ydj1, although 
it contains an atypical, smaller domain II. 
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Figure 2-2. Determination of the ability of wild-type and mutant ERdj3 to bind 
HC in vivo 
(A). A schematic drawing of the domain structure of the various mutants.  In the case of 
one of the domain II mutants, a GSGG linker was added between domain Ia and Ib to aid 
in keeping the protein structure intact.  (B). COS cells were cotransfected with HC and 
either WT ERdj3 or the indicated ERdj3 mutants and metabolically labeled proteins were 
immunoprecipitated as indicated.  Samples were analyzed by reducing SDS-PAGE.  (C). 
COS cells were transfected with each of the ERdj3 constructs alone and analyzed as in 
(B).
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 mutant to γHC, which is consistent with our previous finding that mutation of the HPD 
motif in this domain resulted in better binding of mutant ERdj3 with several different 
substrate proteins in cells (Shen et al., 2005).  Deletion of the Gly/Phe-rich region (ΔG/F) 
did not obviously affect binding to HC, and removing domain III only had a very 
modest effect on binding.  When domain Ia was deleted alone or along with the Gly/Phe-
rich region, we observed a slight decrease in the ability of the mutant proteins to associate 
with the substrate.  Structural data on Ydj1 revealed that domain I is in direct contact 
with a peptide that was co-crystallized with Ydj1 and therefore is very likely to form at 
least part of the substrate binding site (Li et al., 2005).  Domain I of Sis1 also contains a 
similar substrate binding structure based on crystallographic data (Sha et al., 2000; Li et 
al., 2003; Li et al., 2006).  Somewhat unexpectedly, we found that deletion of domain II 
(∆II), which bears little homology to the corresponding domain in Ydj1 and is missing in 
Sis1, had the most dramatic effect on HC binding.   
 
2.3.3 Binding of ERdj3 to purified denatured luciferase in vitro 
A caveat to these data is that binding of even wild-type ERdj3 to γHC in cells can 
only be detected with a chemical cross-linker due to the detergent sensitive nature of its 
association with substrates (Meunier et al., 2002), and the effects of most of the deletions 
are quite modest.  Using PyMol (DeLano Scientific LLC) to model ERdj3 structure, we 
identified the residues that could potentially form the substrate binding patch in domain I 
of ERdj3.  The model indicates that these hydrophobic residues are highly conserved 
between ERdj3 and Ydj1, suggesting that ERdj3 forms same substrate binding motif as 
Ydj1 (Figure 2-3A).  Since we recently demonstrated that ERdj3 could bind to 
chemically denatured luciferase in solution and in a modified ELISA assay (Jin et al., 
submitted), we used this assay to further probe the regions of ERdj3 required for 
substrate binding.  Similar to data obtained for the in vivo binding of the various mutants 
to γHC, we found that deletion either domain Ia or II significantly diminished ERdj3’s 
ability to bind to D-Luc (Figure 2-3B).  According to structural data for Ydj1 and Sis1, 
domain I contains a hydrophobic pocket that forms the substrate binding site (Sha et al., 
2000; Li et al., 2003).  Deletion of domain Ia is likely to distort the overall structure of 
this domain, since it cooperates with domain Ib to form the intact domain I.  Thus data 
obtained with this mutant cannot be clearly interpreted.  When we aligned the structural 
model of ERdj3 with Ydj1, we found that four out of five amino acids in Ydj1’s domain I 
that form the hydrophobic pocket were conserved in ERdj3 (Figure 2-3C).  To examine 
the roles of these amino acids in ERdj3’s ability to bind substrate, we mutated each of 
these four amino acids alone (I113A, V1332A, L226A, F241A), the first two amino acids 
together (I113A-V132A), or all of them together (IVLF-A) to alanine and tested their 
ability to bind to D-Luc in vitro.  We found that except for I113A, all of the point 
mutations or combinations of them affected ERdj3’s ability to bind to D-Luc (Figure     
2-3C).  This suggested that these hydrophobic amino acids are likely to also form the 
substrate binding site in ERdj3, which agrees with the structure model (Figure 2-3A). 
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Figure 2-3. Both domain I and domain II of ERdj3 contribute to its ability to bind 
to D-Luc 
(A) Ribbon diagram of the modeled structure of domain I of ERdj3 (left) showing amino 
acid residues that could potentially form the hydrophobic substrate binding patch 
described for Ydj1.  An overlap of the substrates binding motifs of ERdj3 and 
Ydj1(right).  Grey: substrate peptide; Green: Ydj1; Pink: ERdj3; Red: residues on Ydj1 
that interacted with substrate; Blue: corresponding residues on ERdj3.  (B) Measurement 
of complex formation between wild type and mutant ERdj3 and denatured luciferase.  
The quantity of luciferase bound to WT ERdj3 was set as 100% of control, and the values 
for the mutants were expressed as a percentage of wild type ERdj3.  (C) Measurement of 
complex formation between wild type ERdj3 and point mutants and denatured luciferase. 
Relative binding was determined as in (B). 
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 2.3.4 ERdj3 forms dimer, which is important for substrate binding 
The yeast cytoplasmic DnaJ homologues, Ydj1 and Sis1, form dimers via 
sequences located in their C terminus, which are essential for substrate binding (Sha et 
al., 2000; Wu et al., 2005).  Since ERdj3 is similar to Ydj1 in overall structure, we tested 
whether ERdj3 forms dimers in cells.  First, we made a 3×HA-ERdj3 construct, which 
contains three HA tags at the C terminus of ERdj3 in order to clearly separate it from the 
untagged versions of ERdj3.  Each of tagged and untagged constructs were first 
expressed in COS cells alone.  Cell lysates were prepared and immunoprecipitated with 
Protein A Sepharose beads alone, the anti-ERdj3 serum, or a monoclonal anti-HA 
antibody.  The monoclonal anti-HA antibody interacted only with HA-tagged form of 
ERdj3, whereas the polyclonal anti-ERdj3 recognized both 3HA-ERdj3 and ERdj3 
(Figure 2-4A).  The 3X HA-tagged form of ERdj3 was readily distinguished from ERdj3 
on 10% SDS-PAGE gels.  Next, the 3×HA-tagged form of ERdj3 was co-expressed with 
untagged wild-type ERdj3.  We observed that the anti-HA antibody precipitated both 
3×HA-ERdj3 and ERdj3 at an approximately 1:1 ratio when they were co-expressed 
(Figure 2-4B lane 6), suggesting that 3× HA-ERdj3 and ERdj3 are associated with each 
other in cells as either dimers or multimers.  Unlike ERdj3’s association with substrate, 
ERdj3 dimers are stable in the presence of detergents and can be detected in the absence 
of crosslinker. 
 
It has been reported that tyrosine (Y) 336 on Sis1 plays an important role in 
dimerization (Sha et al., 2000).  Phenylalanine (F) 335 of Ydj1 is the counterpart of Y336 
of Sis1 and is also critical for Ydj1 dimerization (Li et al., 2005; Wu et al., 2005).  
Sequence alignment of Sis1, Ydj1 and ERdj3 identified F326 on ERdj3 as the likely 
counterpart of F335 of Ydj1 and Y336 of Sis1.  Thus, we mutated F326 to either alanine 
(A) or aspartic (D) amino acid on both an untagged or HA-tagged background.  The 
indicated mutants were first expressed in COS cells and immunoprecipitated with either 
Protein A Sepharose beads alone, the anti-ERdj3 serum, or a monoclonal anti-HA 
antibody.  All of the proteins were expressed and migrated to the expected position on the 
SDS-gels.  HA-tagged ERdj3 constructs were recognized by both anti-ERdj3 and anti-
HA antibody, whereas the untagged forms were only precipitated by anti-ERdj3 
antibody.  None of them bound to Protein A Sepharose beads nonspecifically.  To 
examine whether ERdj3 F3326A/D form dimers with wild type ERdj3, HA-tagged wild 
type ERdj3 was co-expressed with the untagged F326A or F326D ERdj3 mutants and 
immunoprecipitation experiments were performed (Figure 2-4B lane 7-12).  We found 
that untagged F326A/D was not co-precipitated along with HA-tagged wild type ERdj3 
when it was precipitated with the anti-HA antibody, demonstrating that the F326A/D 
mutations affected the ability of ERdj3 to form dimers.  We also co-expressed untagged 
F326A/D ERdj3 along with HA-tagged F326A/D ERdj3 (Figure 2-4B lane 13-18).  
Again, we found that the mutation of F326 to either alanine or aspartic acid abolished 
ERdj3’s ability to forms dimers. 
  
The ability of F326D ERdj3 to bind to denatured luciferase was next examined. We 
found that this mutation decreased the binding of ERdj3 to D-Luc, as did deletion of 
domain III (ΔIII), which lacks the dimerization residue (Figure 2-5).  The fact that 
dimerization mutants (F326A/D and ΔIII) diminished the ability of ERdj3 to bind to
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Figure 2-4. ERdj3 forms dimers in cells 
COS cells were transfected with cDNA encoding pSG-ERdj3 (lane1-3), 3×HA-ERdj3 
(lane 4-6) (with HA epitope tagged at its C-terminus), ERdj3 F326A (lane 7-9), F326D 
(lane 13-15), HA-ERdj3 F326A (lane10-12) and HA-ERdj3 F326D (lane 16-18) either 
alone (A) or co-transfected with 3×HA-ERdj3 (B).  Metabolically labeled cell lysates 
were divided into three equal parts and incubated with indicated antibodies.  Samples 
were analyzed by reducing SDS-PAGE. 
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Figure 2-5. Deletion of domain III or mutation of Phe326 to aspartic acid affects 
ERdj3’s substrate binding ability. 
ELISA assay for luciferase binding was performed and quantitated as described in Figure 
2-3B.
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 substrate strongly argues that dimerization is important for ERdj3’s substrate binding, 
which is consistent with what has been reported for Ydj1 and Sis1 (Wu et al., 2005).   
 
2.4 Discussion 
According to their domain conservation with E. coli DnaJ, DnaJ proteins have been 
divided into three subgroups.  Type I and II DnaJ proteins appear to bind directly and 
promiscuously to the unfolded regions of multiple substrates through their substrate 
binding domain, whereas type III proteins either do not bind to unfolded proteins or have 
a very limited client repertoire.  A crystal structure has been obtained for the C terminal 
fragment of Ydj1 (102-384 aa) with a bound peptide (GWLYEIS) (Li et al., 2003).  This 
fragment lacks both the N terminal J domain and G/F rich flexible linker and contains a 
mutation of phenylalanine 335 to aspartic acid, which disrupts its ability to form dimers 
(Li et al., 2003).  The structure revealed that the peptide bound to a hydrophobic pocket 
on domain I and made contact with five different polar residues in this pocket.  The 
importance of these residues in binding to peptide was confirmed with mutagenesis 
studies (Li et al., 2005).  The structure of the corresponding C terminal region of Sis1 had 
been solved previously, but in this case there was no substrate bound (Sha et al., 2000).  
Although the amino acid sequence homology is not high between these two proteins in 
this region, their tertiary structures were nearly identical, except that Sis1 lacks the Cys-
rich domain II (Li et al., 2003), suggesting that domain I of Sis1 is likely to contain the 
substrate binding site.  This possibility was supported by mutagenesis studies in which 
mutations in the hydrophobic pocket affected Sis1’s ability to bind substrate (Lee et al., 
2002).  Our data revealed that ERdj3 should be considered to be a type I DnaJ protein 
even though its domain II is quite different from that of Ydj1.  We found that most of the 
hydrophobic amino acids that form the substrate binding site on Ydj1 are conserved in 
ERdj3.  Mutations of these amino acids alone or in combination affected ERdj3’s ability 
to bind to D-Luc in vitro.  Overall these studies suggest that this substrate binding 
structure may be common to all type I and II DnaJ proteins.  This possibility is further 
supported by earlier peptide binding studies on DnaJ (Rudiger et al., 2001), where it was 
found that DnaJ preferred to bind peptides with hydrophobic features. 
 
Type I and II DnaJ proteins form homodimers, and the dimerization motif is 
located in the C terminus of these proteins (domains III and II respectively).  Both Ydj1 
and Sis1 dimerize via a number of hydrophobic residues that form a hydrophobic patch. 
Mutation of F335 of Ydj1 to aspartic acid disrupted the hydrophobic patch and yielded 
monomers (Li et al., 2005).  In the case of Ydj1, residues in β-strands in domain III of 
one monomer can interact with those of another monomer to contribute to homodimer 
formation (Wu et al., 2005).  Disruption of dimer formation for both Ydj1 and Sis1 
results in severe defects in their ability to bind to substrates and to facilitate Hsp70’s 
ability to refold substrates (Wu et al., 2005).  We demonstrated that ERdj3 forms dimers 
or multimers in cells.  Our in vivo study revealed that the F326A/D mutation abolished 
ERdj3’s ability to form dimers.  Similar to data obtained with Ydj1, this affected ERdj3’s 
ability to interact with substrates.  This finding supports a model where the dimerization 
of both type I and II DnaJ proteins allows the two substrate binding domains to form a 
clamp around unfolded substrates (Landry, 2003).  Although type III DnaJ proteins are 
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 much less conserved, some of them have been shown to have substrate proteins 
(Gruschus et al., 2004).  Although it has not been examined, it is possible that this group 
of proteins does form dimers or conversely that dimerization is more important for the 
ability to interact with a broader range of substrates, which is a hallmark of the type I and 
II DnaJ proteins. 
 
Our in vivo assay to examine the binding of ERdj3 mutants with HC revealed that 
the ΔIII ERdj3 mutant, which lacked the dimerization domain, bound to HC as well as 
WT ERdj3, whereas in the in vitro assay, the association of the ΔIII ERdj3 with D-Luc 
was significantly diminished.  We can think of four possibilities to account for this, 
which are not mutually exclusive.  First, in the in vivo assays, a crosslinker was used, 
which could serve to stabilize transient interactions between ERdj3 and the substrate.  
Second, since a number of chaperones form a complex in the ER of cells, which includes 
BiP (Meunier et al., 2002), it is possible that the substrate is binding to one of these and 
not to the ΔIII ERdj3 mutant directly.  Third, although deletion of domain III or mutation 
of F326 to alanine or aspartic acid disrupted dimer formation, the use of crosslinking 
agents revealed that some dimers could be still be detected with these mutants (data not 
shown).  Thus, it is conceivable that the use of crosslinker might stabilize the interaction 
between the ΔIII mutant and endogenous ERdj3, which would result in the apparent 
association of ΔIII with HC in vivo.  Finally, it is possible that the differences we are 
observing in the in vivo versus in vitro assay are actually reflecting distinct affinities of 
ERdj3 for these two substrates.  
 
Our results argue that domain II is critical for ERdj3’s substrate binding ability.  
This Cys-rich region in other type I proteins contributes to their chaperone activities by 
affecting the transfer of substrate to the Hsp70 partner (Lu et al., 1998).  Previously we 
reported that ERdj3 contains intra-chain disulfide binds (Shen et al., 2005).  Only four 
cysteines are found in ERdj3, and they are all in domain II, arguing that they are 
responsible for the intra-chain disulfides and do not form a zinc-finger binding site as in 
other type I DnaJ proteins, which was confirmed by recent studies (Marcus et al., 2007).  
Although domain II of ERdj3 is very different from that of Ydj1, it is very highly 
conserved among ERdj3 proteins in different species (about 80% identity between human 
and C. elegans).  However, Sis1, which possesses a very a similar overall substrate 
binding structure as Ydj1, does not possess a domain II.  Of interest, the structure of the 
Ydj1 C-terminal fragment could only be obtained with a bound peptide, whereas Sis1’s 
was crystallized without the presence of a peptide.  Considering these facts, we propose 
that domain II could play a role in stabilizing domain I of type I DnaJ proteins in the 
absence of substrate.  Alternatively is it possible that the substrate binding repertoire of 
type I proteins is different than that of type II DnaJ proteins and therefore requires a more 
complex binding site.  But the fact that both Ydj1 and Sis1 binds to denatured luciferase 
in vitro argues against this possibility. 
 
In summary, we have demonstrated that domain I and II of ERdj3 contribute to 
substrate binding.  The hydrophobic residues in domain I of ERdj3 apparently form a 
substrate binding site that resembles that of Ydj1.  The role of domain II is less clear but 
could be important in maintaining domain I in a configuration that is critical for substrate 
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binding.  In addition we found that ERdj3 exists as a dimer in cells, which contributes to 
substrate binding.  Together these data help to define the structural elements required for 
substrate binding for DnaJ proteins. 
 
 CHAPTER 3. FUNCTIONAL CONSERVATION BETWEEN ERDJ3 AND YDJ1, 
DNAJ HOMOLOGUES IN THE MAMMALIAN ER AND YEAST 
CYTOPLASM 
 
 
3.1 Introduction 
Hsp70 proteins constitute a highly conserved group of molecular chaperones that 
are found in all organisms and all cellular organelles.  They play critical roles in most 
cellular functions due to their ability to bind to unfolded regions on nascent proteins or 
subunits of heteromeric complexes in a nucleotide-dependent manner (Munro & Pelham, 
1986; Liberek et al., 1991; Buchberger et al., 1995).  The ATPase activity of Hsp70 
proteins is tightly regulated by DnaJ proteins that increase the hydrolysis of ATP leading 
to enhanced binding of the Hsp70s to substrates (Liberek et al., 1991) and nucleotide 
exchange factors that release them (Liberek et al., 1991; Chung et al., 2002).  Some DnaJ 
proteins bind directly to unfolded regions on substrate proteins through their substrate 
binding domain and serve to recruit the ATP-bound form of their Hsp70 partner to the 
unfolded substrate (Rudiger et al., 2001).  The number of DnaJ proteins in most 
organisms/organelles far exceeds that of Hsp70s.  A single Hsp70 can interact with 
multiple DnaJ proteins and form unique DnaJ/Hsp70 pairs (Caplan et al., 1993; 
Cheetham & Caplan, 1998; Sahi & Craig, 2007).  This has led to the hypothesis that 
different DnaJ proteins selectively interact with their Hsp70 partner and regulate its 
specific functions. 
 
DnaJ proteins regulate the ATPase activity of their Hsp70 partner via direct 
interaction with the nucleotide binding domain, which occurs through a highly conserved 
~70 amino acid J domain (Wall et al., 1994).  J domains contain a signature tri-peptide 
HPD (Histidine-Phenylalanine-Aspartic acid) motif, which is critical for inducing 
Hsp70s’ ATPase activity (Wall et al., 1994; Tsai & Douglas, 1996).  In many cases DnaJ 
proteins are not interchangeable between organelles or organisms even though the J 
domains are highly conserved.  This suggests that there is some specificity between 
DnaJ/Hsp70 pairs; at the level of substrate recognition, the ability to functionally interact 
with the particular Hsp70, or the ability to fold appropriately within a given organelle.  A 
recent genetic study was conducted to test the ability of 13 different yeast cytosolic DnaJ 
proteins to functionally interact with resident Hsp70s (Sahi & Craig, 2007).  It was found 
that in many cases the ability to stimulate the ATPase activity of a particular Hsp70 was 
sufficient to constitute a functional pair.  However, specific features of DnaJ proteins, 
such as the ability to interact with substrates, can also be required (Johnson & Craig, 
2001). 
 
ERdj3 is a mammalian ER type I DnaJ family member, which binds to unfolded 
substrates (Yu et al., 2000; Meunier et al., 2002; Shen et al., 2005).  The structural 
features of ERdj3 that contribute to substrate binding were found to closely resemble 
those of Ydj1 (Chapter 2).  In addition to identifying the hydrophobic residues in domain 
I that are likely to form the substrate binding site, it was found that ERdj3 dimerizes, 
which significantly enhances substrate binding.  Somewhat unexpectedly, it was 
ascertained that domain II of ERdj3, which is significantly different from the domain II in 
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 other type I DnaJ proteins, including Ydj1, was most important for substrate binding.  
The identification of critical features for substrate binding encouraged us to attempt to 
establish their roles in vivo using yeast complementation studies and to probe the 
requirements for establishing functional Hsp70/DnaJ pairs. 
 
We found that Ydj1 bound to BiP and ERdj3 substrates when it was expressed in 
the mammalian ER.  The reciprocal experiment was employed to determine whether 
ERdj3 could be functional in yeast.  A cytosolically expressed, ER membrane tethered 
form of ERdj3 rescued the slow growth phenotype of the hlj1∆ydj1-151 mutant strain, 
while the ERdj3 mutations that affected substrate binding did not.  Perhaps most 
surprisingly, deletion of domain II also inhibited complementation even though domain II 
of ERdj3 is much smaller and has a very different sequence than that of domain II of 
Ydj1.  Expression of ERdj3 in the yeast ER did not rescue the growth defect of yeast 
containing mutations in two lumenal DnaJ homologs, SCJ1 and JEM1.  This was likely 
due to the inability of ERdj3 to stimulate the ATPase activity of yeast BiP/ Kar2p, the ER 
lumenal Hsp70.  Our studies provide further insights into requirements for producing 
functional Hsp70/DnaJ pairs and argue that in addition to requirements for functional 
interactions between these two proteins, the substrate binding properties of DnaJ proteins 
might be critical to specify the in vivo function of chaperone pairs.  
 
3.2 Materials and Methods 
 
3.2.1 Preparation of Ydj1 and ERdj3 constructs 
To express Ydj1 in the mammalian ER, PCR was used to engineer an ER-targeting 
signal-sequence onto the N-terminus of Ydj1 using pBS-Ydj1 as a template.  Primer pairs 
include: 
5’ primer: CGGGATCCatggctccgcagaacctgagcaccttttgcctgttgctgctatacctcatcggg 
gcggtgattgccGTTAAAGAAACTAAGTTTTACGATATTCTAGGTGTTCC and 3’ 
primer: CGGGATCCTCATTGAGATGCACATTGAACACCTTC.  
The lower case letters represent the inserted ER targeting signal sequence and the italics 
indicate a BamHI site.  The PCR product was digested with BamHI and inserted into 
3HA-DSL mammalian expression vector.  The translation stop codon in the 3HA-DSL- 
ssYdj1 construct was destroyed using the Quick change site-directed PCR kit 
(Stratagene) with the following primers.  
5’ primer: GAAGGTGTTCAATGTGCATCTCAAGGATCCCCGGAATTCCTCGAG 
3’ primer: CTCGAGGAATTCCGGGGATCCTTGAGATGCACATTGAACACCTTC 
The resulting PCR product has an HA tag at the C-terminus, which was already present in 
the 3HA-DSL vector.  A Kozak sequence (underlined) was inserted at the translation start 
site of 3HA-DSL- ssYdj1 using Quick change PCR kit with the following primers: 
5’primer:GTTTAAACGGATCCACCCGGGACAGAGGAACCATGGCTCCGCAGAA
C and 3’primer:GTTCTGCGGAGCCATGGTTCCTCTGTCCCGGGTGGATCCGTTTA 
AAC 
A construct that would produce a soluble luminal form of Ydj1 (ssYdj1 C406S) was 
generated by mutating the C terminal farnesylation site with the primer pair: 
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 5’ primer: GGTGGCGAAGGTGTTCAAAGTGCATCTCAAGGATCCCCG and 3’ 
primer: CGGGGATCCTTGAGATGCACTTTGAACACCTTCGCCACC 
 
To express ERdj3 in yeast, two constructs were produced under the control of the 
GPD promoter in the multi-copy pGPD426 vector.  Full length ERdj3 containing a signal 
sequence for luminal ER expression was made by PCR using 3HA-DSL-ERdj3 vector as 
the template with the following primer pair: 
5’ primer: CGGAATTCGGACCCGGGAC  
3’ primer: CGGGATCCATATCCTTGCAGTCCATTGTATACCTTCTG 
The resulting PCR product was digested with EcoRI and BamHI and inserted into the 
pGPD426 yeast expression vector (pGPD-ERdj3).  For cytosolic expression at the ER 
membrane, CaaX-ERdj3 was generated using the following primer pair with 3HA-DSL-
ERdj3 serving as the template:   
5’ primer: CGGGATCCGGAACCATGGGACGAGATTTCTATAAGATCTTGGGG   
3’ primer: CCCAAGCTTTCATTGAGATGCACATTGCAGTCCATTGTATACCTTC 
TGC 
The resulting PCR product lacked the N-terminal signal sequence, and the C-terminal GY 
was replaced with a “CaaSQ” farnesylation sequence.  The PCR product was digested 
with BamHI and HindIII and subcloned into the pGDP vector (pGDP-CAAX-ERdj3) to 
allow it to be expressed in yeast.  All mutants were generated by QuickChange PCR with 
the primer pairs previously described (Chapter 2). 
 
3.2.2 Expression and detection of Ydj1 in mammalian cells 
Cells were transfected with the indicated vectors using the FuGENE 6 transfection 
reagent (Roche).  After 48 hours, cells were labeled with 35S Translabel (Amersham 
Biosciences) for 3h, and cell lysates were prepared as described previously (Jin et al., 
submitted).  To stabilize complexes between the various DnaJ-like proteins and either 
BiP or substrate, cells were treated with 150 μg/ml 3,3’-dithio-bis (propionic acid N-
hydroxysuccinimide ester:  DSP) for 1h on ice and lyzed in NP40 lysing buffer after 
quenching with 100 μl of 1M glycine.  Solubilized proteins were incubated with the 
indicated antisera followed by precipitation with Protein A Sepharose beads.  The 
immunoprecipitated complexes were subjected to SDS-PAGE and analyzed under 
reducing conditions.  The signal was enhanced using Amplify (Amersham Bioscience) 
and detected by autoradiography. 
 
3.2.3 Protein expression, purification and ATPase assay 
His-tagged recombinant murine ERdj3 (wild type and mutants) and hamster BiP 
proteins were expressed in E. coli M15 cells and purified under non-denaturing 
conditions using Ni2+-agarose (Qiagen QIAexpress System) as described (Jin et al., 
submitted).  Briefly, ERdj3 proteins were induced with 0.1 mM isopropyl β-D-
thiogalactoside (Sigma) followed by growth for 18 h at 18°C, whereas the BiP protein 
was induced with 1mM IPTG at 37°C for 2hrs.  ERdj3 recombinant proteins were stored 
at -20°C in 25 mM sodium phosphate buffer containing 150mM NaCl, 0.02% Triton X-
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 100, 50% glycerol and Complete EDTA-Free Protease inhibitor cocktail tablet (Roche). 
BiP protein was stored in 20mM HEPES buffer (pH 7.2) with 50mM KCl, 5mM MgCl2, 
0.01% NP-40, 50% glycerol, and Complete EDTA-Free Protease inhibitor cocktail tablet.  
 
3.2.4 ATPase assays 
The following proteins were purified using previously established protocols: Ssa1p 
(McClellan et al., 1998), Ydj1p (Cyr et al., 1992), GST-tagged J-domain of Hlj1p 
(Youker et al., 2004), hexahistidine-tagged yeast BiP/Kar2p (McClellan et al., 1998), and 
the GST-tagged J-domain of Sec63p (Corsi & Schekman, 1997).  Steady-state ATPase 
assays using the indicated molar ratios of DnaJ protein to Hsp70 were performed as 
described (Cyr et al., 1992; McClellan et al., 1998). 
 
3.2.5 Rescue of the slow growth phenotype of the Ydj1 mutant strain  
The following Saccharomyces cerevisiae yeast strains were used for 
complementation studies: HLJ1 YDJ1 (MAT ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-
1 can1-100), hlj1 ydj1-151 (MAT ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-
100 hlj1::TRP1 ydj1-2::HIS3 LEU2::ydj1-151) (Youker et al., 2004), SCJ1 JEM1 
(MAT lys2-801 leu2-3,112 his3-200 trp1-901 ura3-52 suc2-9) and scj1 jem1 
(MAT ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100 scj1::TRP1 
jem1::LEU2) (Nishikawa & Endo, 1997).  The yeast strains were grown to logarithmic 
phase at 26°C in yeast extract–peptone–dextrose medium containing 2% glucose and 
transformed with the indicated plasmids using lithium acetate (Ito et al., 1983).  The 
resulting transformants were selected and grown to logarithmic phase at 26°C in 
synthetic complete medium containing 2% glucose.  10-fold serial dilutions were spotted 
onto solid medium and cultured at the indicated temperatures for 2 days. 
 
3.3 Results 
 
3.3.1 Ydj1 expressed in the mammalian ER binds to BiP and ERdj3 substrates 
We found that the mammalian ER localized DnaJ orthologue, ERdj3, appears to be 
structurally very similar to Ydj1, a yeast cytosolic DnaJ protein (Chapter 2) with the 
exception of domain II, which was demonstrated to be important for substrate binding 
(Figure A-1).  To better understand restrictions guiding Hsp70/DnaJ pairs, mammalian 
BiP was co-expressed in COS cells with a C-terminal HA-tagged ERdj3 or two different 
Ydj1 constructs engineered with an N-terminal ER signal-sequence and a C-terminal HA 
tag.  In one construct, Ydj1’s farnesylation site was removed (ssYdj1C406S) and the 
other retained it (ssYdj1).  Both can be expressed in mammalian ER (Figure A-2).  To 
determine their ability to associate with BiP, ssYdj1 or ssYdj1 C406S and BiP were co-
expressed in COS cells.  Forty-eight hours post-transfection, cells were metabolically 
labeled and treated with DSP to stabilize BiP: DnaJ protein interactions (Meunier et al., 
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2002).  ERdj3 and BiP were co-expressed as a positive control for association.  Co-
immunoprecipitation experiments revealed that both Ydj1 proteins could associate with 
BiP as well as ERdj3 did (Figure 3-1A), regardless of whether the complex was detected 
with an anti-BiP or an anti-HA monoclonal antibody that recognized the epitope tag on 
the DnaJ proteins.  Neither of the Ydj1 proteins bound nonspecifically to Protein-A 
Sepharose beads.   
 
The ability of Ydj1 to bind to an immunoglobulin κ light chain (κLC), which is a 
substrate of both BiP and ERdj3 (Shen et al., 2005) was examined.  Cells were co-
transfected with constructs encoding κLC along with either ERdj3 or ssYdj1.  It was 
found that ssYdj1 associated with κLC as efficiently as ERdj3 (Figure 3-1B).  The fact 
that an ER expressed form of Ydj1 could interact with both BiP and κLC suggested that 
Ydj1 was likely to be functional in the ER of mammalian cells.  This led to the possibility 
that ERdj3 might be functional in yeast.   
 
3.3.2 Overexpression of ERdj3 does not rescue the temperature-sensitive defect of the 
Δscj1Δjem1 strain 
Because ERdj3 is an ER localized protein that contains intra-chain disulfide bonds, 
its ability to function in the yeast ER was tested first.  Scj1 and Jem1 are two yeast ER 
DnaJ proteins that interact with Kar2p, the yeast ER Hsp70 (Schlenstedt et al., 1995).  
They are required for multiple ER functions including protein folding in the yeast ER and 
ER associated degradation (ERAD) (Nishikawa et al., 2001).  Because Scj1 has a similar 
apparent molecular weight as ERdj3 and is also a soluble protein, it has been suggested to 
be the homolog of ERdj3 (Figure A-1).  Loss of both Scj1 and Jem1  (Δscj1Δjem1) 
induces the unfolded protein response (Nishikawa and Endo, 1997; Silberstein et al., 
1998) and reduces ERAD efficiency for soluble ERAD substrates.  Growth of the 
Δscj1Δjem1 strain is unaffected at 26˚C but exhibits a slow growth phenotype at elevated 
temperatures (Nishikawa & Endo, 1997).  An ERdj3 construct was created that could be 
expressed under the control of the GPD promoter in the multi-copy pGPD426 vector.  
Wild type ERdj3 contains an ER signal sequence and thus is targeted to the ER, while the 
CaaX-ERdj3 mutant no longer contains the ER targeting signal sequence and has a 
CaaSQ farnesylation sequence at the C-terminus, targeting it to the cytosolic side of the 
ER membrane.  The farnesylation sequence is the same as that found in Ydj1 and is 
necessary for Ydj1’s function at elevated temperatures (Caplan et al., 1992).  Expression 
of ERdj3 did not affect the growth of wild-type Scj1Jem1 yeast cells (Figure 3-2A).  
However, ER expressed ERdj3 was unable to rescue the slow growth phenotype of the 
∆Scj1∆Jem1 strain at elevated temperatures (Figure 3-2A).  This was not due to poor 
expression of mammalian ERdj3 in the yeast ER as determined by fluorescence staining 
(data not shown).  As a major function of DnaJ proteins is to stimulate the ATPase 
activity of their Hsp70, we examined the ability of ERdj3 to stimulate the ATPase 
activity of Kar2p.  As expected, the basal ATPase activity of Kar2p was quite low but 
could be stimulated ~4.3 fold by the J domain of Sec63, a yeast ER DnaJ (Corsi & 
Schekman, 1997).  However, ERdj3 only modestly enhanced the ATPase activity of 
Kar2p (about 1.3 fold), suggesting that this might be the reason that ERdj3 could not 
complement the ∆Scj1∆Jem1 strain. (Figure 3-2B) 
  
 
Figure 3-1. Mammalian ER expressed Ydj1 interacts with both BiP and κLC 
(A) Cos cells were co-transfected with cDNAs encoding BiP and the indicated HA-
tagged ERdj3 or Ydj1 constructs.  Metabolically labeled, cross-linked cell lysates were 
immunoprecipitated with anti-HA, anti-BiP or Protein A Sepharose alone.  Isolated 
proteins were separated by reducing SDS-PAGE.  (B) Cos cells were co-transfected with 
cDNAs encoding κLC and either ERdj3 or Ydj1 constructs. Samples were analyzed as 
described in (A).
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Figure 3-2. ER expressed ERdj3 does not rescue the slow growth phenotype of the 
scj1jem1 strain   
(A) Ten-fold serial dilutions were performed on selective media of wild-type 
(SCJ1JEM1) and mutant (scj1 jem1 ) yeast strains containing an empty vector (GDP), 
a vector for the expression of an ER-targeted form (ERdj3), or a vector encoding a 
cytosolically localized form (CaaX) of full-length ERdj3. Each protein was expressed 
from a multi-copy vector containing the constitutive PGPD promoter.  The plates were 
incubated for 2 days at the indicated temperatures.  (B) ERdj3 does not stimulate the 
ATPase activity of Kar2p.  The ATPase activity of Kar2p was measured either by itself 
or in the presence of either ERdj3 or the J domain of Sec63.  Reactions contained 1 mg of 
Kar2p, 1:1 molar ratio of Kar2p: Sec63 J domain, or an eight-fold molar excess of the 
ERdj3 protein.  ATPase activity is expressed as nmoles of ATP hydrolyzed per milligram 
of protein per minute (nmol ATP hydrolyzed/mg/min).  Data represent the means of a 
minimum of three independent experiments.
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 3.3.3 Overexpression of cytosolically localized ERdj3 rescues the temperature-sensitive 
defect of the hlj1Δ ydj1-151 strain 
Since our previous data suggested that ERdj3 was structurally very similar to Ydj1, 
we next determined if it could compensate for the loss of Ydj1.  Ydj1p and Hlj1p (two 
yeast cytosolic DnaJ proteins) interact with Ssa1p, the yeast cytosolic Hsp70 and are 
functionally redundant (Youker et al., 2004).  The hlj1Δ ydj1-151 mutant strain lacks 
Hlj1p and expresses a conditional mutant form of Ydj1, Ydj1-151p.  This mutant shows 
reduced efficiency for ER-associated degradation (ERAD) and exhibits a slow growth 
phenotype at elevated temperatures (Youker et al., 2004).  Expression of CaaX-ERdj3 in 
the cytosol of wild-type HLJ1 YDJ1 yeast cells did not affect their growth (Figure 3-3A).  
However, when the hlj1Δ ydj1-151 strain expressing CaaX-ERdj3 was grown at elevated 
temperatures, we found that the expression of CaaX-ERdj3 allowed growth at 
temperatures up to 37˚C
 
(Figure 3-3A).  Recombinant ERdj3 was tested for its ability to 
stimulate the ATPase activity of Ssa1 and found to do so at a level similar to Hlj1 (Figure 
3-3B).  These results demonstrated that CaaX-ERdj3 could act as a cochaperone of Ssa1p 
and compensate for the loss the Ydj1, which allowed us to next examine the requirements 
for substrate binding by expressing the various ERdj3 mutants.  
 
3.3.4 Mutations in ERdj3 that affect substrate binding are unable to rescue the slow 
growth phenotype of hlj1Δ ydj1-151 strain 
The binding of ERdj3 to substrates was recently shown to be dependent on three 
things: 1) the presence of domain II, 2) the pocket formed by hydrophobic amino acids in 
domain I, and 3) dimerization, which occurs through the interactions in the C-terminal 
region of which phenylalanine 326 is critical (Chapter 1).  To determine whether the 
ability to bind substrates is required for ERdj3 to compensate for the loss of Ydj1, seven 
ERdj3 mutants were expressed in yeast.  These included ones in which domain II was 
either simply deleted (∆II) or replaced by a “GSGG” linker sequence (∆II-GSGG), two 
mutants in which dimerization was inhibited (F326A and F326D), and finally, two single 
amino acid substitutions in domain I (I134A and L208A) and one in which all four 
hydrophobic residues affecting substrate binding were altered (IVLF-A).  All mutations 
were constructed on the CaaX-ERdj3 background.  Expression of each of these mutants 
in the HLJ1 YDJ1 strain did not affect cell growth (Figure 3-4A), however, none of them 
were able to rescue the temperature-sensitive slow phenotype of the hlj1Δ ydj1-151 strain 
(Figure 3-4B).  Indeed, expression of most of the mutants actually enhanced the 
temperature-sensitivity of this strain (Figure 3-4B).  The fact that the CaaX-F326A/D 
mutants were unable to rescue the slow growth phenotype, argues that dimerization of 
CaaX-ERdj3 is required for its function in yeast.  The failure of these mutants to 
complement was not due to an inability to stimulate the ATPase activity of Ssa1, since all 
mutants were able to stimulate ATP hydrolysis to levels that are comparable to both Hlj1 
and wild-type ERdj3 (Figure 3-4C).  Nor was it likely to be due to inadequate expression, 
as at least two of the mutants, CAAX-∆II-GSGG and CAAX-F326D, were expressed at 
similar levels as the wild-type CaaX-ERdj3 protein (Figure A-3).  These results argue 
that the cytosolically disposed ERdj3 requires its substrate binding activity to constitute a 
functional pair with Ssa1 in yeast.  
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Figure 3-3. Cytosolic expression of ERdj3 rescues the temperature-sensitive 
growth phenotype of the hlj1∆ydj1-151 strain 
(A) an empty vector (GDP), a vector containing an ER-targeted form (ERdj3), or a vector 
engineered to produce a cytosolically localized form (CaaX) of full-length ERdj3 were 
expressed in wild-type (HLJ1YDJ1) and mutant (hlj1∆ydj1-151) yeast strains as 
described in Figure 3-2A.  The plates were incubated for 2 days at the indicated 
temperatures.  (B) ERdj3 robustly stimulates Ssa1’s ATPase activity.  The ATPase 
activity of Ssa1 was measured either by itself or in the presence of ERdj3 or Hlj1 as 
described in Figure 3-2B.  The molar ratio of Ssa1 to the DnaJ proteins is 1:2.
  
 
Figure 3-4. ERdj3 substrate binding mutants cannot rescue the temperature 
sensitive growth phenotype of the hlj1∆ydj1-151 strain.   
Cytosolically forms (CaaX) of wild type or mutant ERdj3 were expressed in wild type 
(HLJ1YDJ1) (A) or mutant (hlj1∆ydj1-151) yeast strains (B).  They were plated and 
allowed to grow as described in Firgure 2.  (C) All ERdj3 mutants stimulate Ssa1’s 
ATPase activity.  The ATPase activity of Ssa1 was measured either by itself or in the 
presence of the indicated DnaJ proteins as described in Figure 3-2B.  The molar ratio of 
Ssa1 to DnaJ proteins is 1:2. 
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 3.4 Discussion 
As cochaperones of Hsp70, DnaJ proteins allow Hsp70s to function by stimulating 
their ATPase activity.  The fact that a given Hsp70 in many organelles often has multiple 
DnaJ cochaperones has led investigators to suggest that association with different DnaJ 
proteins determines the functional diversity of Hsp70 proteins.  We demonstrated that 
ER-expressed Ydj1 associated with BiP and specific ERdj3 substrates in mammalian 
cells, which led to a further investigation of the principles regulating the formation of 
functional DnaJ/Hsp70 pairs.  We found that ERdj3 cannot compensate for the loss of 
yeast Scj1, which is an ER localized Dna J protein.  However, ERdj3 could compensate 
for the loss of Ydj1 when it was expressed in the yeast cytosol.  Since ATPase activity is 
imperative for the function of Hsp70, the failure of ERdj3 to efficiently stimulate the 
ATPase activity of Kar2p, a Hsp70 in yeast ER, may explain the inability of ERdj3 to 
compensate Scj1.  It was also demonstrated that CaaX-ERdj3 can functionally interact 
with Ssa1 and compensate the loss of Ydj1.  These results suggest that both Ydj1 and 
ERdj3 can interact with an alternative Hsp70 and must be able to bind to at least some 
substrates in the other cell type, even though they originate from different organelles in 
different organisms.  In some cases the ability to stimulate Hsp70 ATPase activity is 
sufficient for many cellular processes (Sahi & Craig, 2007).  Our data suggests this is not 
sufficient in the case of the ERdj3/Ssa1 pair, as all of the substrate binding mutants were 
able to stimulate the Ssa1’s ATPase activity in vitro but were unable to compensate for 
the loss of Ydj1 in vivo.  This is in contrast to a recent study where growth defects caused 
by the loss of Ydj1 could be attenuated by the expression of various cytosolic DnaJ 
proteins or even only their J domains (Sahi & Craig, 2007).  However, unlike present 
study, their study was done in the background only deleting Ydj1.  It is likely that other 
cytosolic DnaJ proteins (Hlj1) can functionally overlap with Ydj1 in vivo.  
 
In the present study, we found that the ΔII mutant retains its ability to stimulate 
Ssa1 but cannot compensate for the loss of Ydj1, suggesting that deletion of domain II 
does not grossly affect ERdj3’s overall structure and agreeing with previous findings that 
domain II has an essential role in both Ydj1 and DnaJ function (Szabo et al., 1996; Lu et 
al., 1998).  It was suggested that the cysteines of domain II are important for maintaining 
the ability of these DnaJ proteins to bind substrate or to cooperate with Hsp70 in 
substrate folding.  In contrast to other type I DnaJ proteins whose cysteine residues form 
zinc binding sites, the four cysteines that are present in ERdj3 form intra-chain disulfide 
bonds in domain II.  In a recent study using mutational analyses, these cysteines were 
argued to be essential for the in vitro binding of ERdj3 to denatured thyroglobulin and 
immunoglobulin (Marcus et al., 2007).  Because the yeast cytosol has a more reducing 
environment than that of the mammalian ER, one might expect that the critical disulfide 
bonds would not form.  The fact that ERdj3 was able to compensate for loss of Ydj1 
argues that either the disulfide bonds do form even in the reducing environment or that 
they are not necessary for function in this context.  In support of the first possibility, it 
has been reported that ER proteins which fold quite stably can form disulfide bonds even 
in the presence of DTT (Hellman et al., 1999).  In addition, we previously demonstrated 
that reduced ERdj3 can interact not only with BiP but also with substrate in vivo when 
cells are treated with DTT (Shen et al., 2005).  Thus, the requirement for these cysteines 
in the mutational study might reflect either the presence of altered amino acids in these 
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positions or a more stringent requirement for the disulfide bonds in these particular in 
vitro assays.  It is also conceivable that the binding of Zn2+ to the cysteines in domain II 
of ERdj3 when it is expressed in the yeast cytosol is able to stabilize this domain and that 
conversely the formation of disulfide bonds in domain II of Ydj1 when it is in the 
mammalian ER serves a similar purpose. 
 
Previous crystallographic studies of the peptide binding fragment of Ydj1 and Sis1 
(Sha et al., 2000; Li et al., 2003; Li & Sha, 2005) and the mutagenesis study of ERdj3’s 
substrate binding domain (Chapter 1) suggest that type I and type II DnaJ proteins are 
likely to possess a very similar substrate binding structure.  Since the substrate binding 
domains of Ydj1 and Sis1 are required for robust growth of yeast cells (Johnson et al., 
2001), a number of genetic reconstitution studies have been performed (Sahi & Craig, 
2007).  Sis1, which is a type II family member, is able to complement loss of Ydj1 (Sahi 
& Craig, 2007), as was ERdj3 in the present study.  However, loss of Sis1 is not 
complemented by Ydj1 (Luke et al., 1991).  Based on our studies showing that substrate 
binding is important for complementation, it is reasonable to suggest that Sis1 is able to 
bind Ydj1 substrates that are critical for growth, whereas Ydj1 may not be able to interact 
with an essential Sis1 substrate.  The fact that the actual sequence of domain I of these 
DnaJ proteins is not highly conserved is consistent with this possibility. 
 
These studies demonstrate that both substrate binding and the ability to stimulate 
Hsp70 ATPase activity are crucial in the formation of functional DnaJ/Hsp70 pairs.  They 
further suggest that DnaJs exhibit more promiscuity in binding to various substrates than 
in interaction with Hsp70s.  This discovery has implications for models in which different 
DnaJ proteins allow Hsp70s to contribute to diverse and sometimes opposing cellular 
functions. 
 CHAPTER 4. REGULATED RELEASE OF ERDJ3 FROM UNFOLDED 
PROTEINS BY BIP1 
 
 
4.1 Introduction 
The Hsp70 family of molecular chaperones is a highly conserved, widely 
expressed, and well-studied group of proteins.  These chaperones are found in all 
organisms where they play a role in every cellular organelle and are essential to nearly all 
cellular processes.  The binding of Hsp70 proteins to non-native structures on a vast array 
of substrate proteins can serve to stabilize folding intermediates, prevent their 
aggregation, and aid in protein folding and assembly.  This is achieved via direct 
interaction of the C-terminal substrate binding domain (SBD) of Hsp70 proteins with 
exposed hydrophobic residues on substrate proteins (Erbse et al., 2004).  Peptide binding 
studies have been performed on BiP (Flynn et al., 1991; Blond-Elguindi et al., 1993), the 
Hsp70 cognate of the mammalian endoplasmic reticulum (ER), on Hsc 70 (Gragerov & 
Gottesman, 1994), a cytosolic mammalian Hsp70, and on DnaK (Rudiger et al., 1997), 
the E. coli family member.  Although differences exist, overall the studies suggest that 
Hsp70 proteins prefer peptides of 5 – 10 amino acids, which are predominantly 
hydrophobic in nature, and which have been estimated to occur approximately every 16-
20 amino acids in the average protein (Flynn et al., 1991).  In the case of BiP, the 
preferred peptides contain hydrophobic amino acids in alternating positions (Blond-
Elguindi et al., 1993).  This configuration is most compatible with a preference for 
extended chains in which the hydrophobic amino acids would be oriented in a single 
direction to engage the peptide binding pocket of the Hsp70 protein, a possibility that is 
supported by NMR (Landry et al., 1992) and crystallographic (Zhu et al., 1996) studies.   
 
The binding and release of substrates to the SBD of Hsp70 proteins is tightly 
regulated by the highly conserved N-terminal nucleotide binding domain (NBD) (Liberek 
et al., 1991b), which can bind either ATP or ADP.  When ATP occupies the cleft of the 
NBD, the SBD is in an open configuration, which has both a high on and high off rate for 
unfolded proteins.  The hydrolysis of ATP to ADP results in a closure of the lid on the 
SBD, which stabilizes the interaction with bound proteins.  Discharge of the unfolded 
protein occurs when ADP is released and exchanged for ATP.  This reopens the lid on the 
SBD, which allows the bound substrate to be released and provides an opportunity for it 
to fold.  A number of recent studies shed light on the interaction between the two 
domains, which controls the activity of this group of chaperones (Jiang et al., 2005; 
Vogel et al., 2006a; Vogel et al., 2006b; Liu & Hendrickson, 2007; Awad et al., 2008).   
 
The Hsp70 ATPase cycle, which is essential to the chaperoning process, is 
controlled by a number of co-factors that regulate either ATP hydrolysis or nucleotide 
exchange.  DnaJ was originally identified along with DnaK (Hsp70) in a genetic screen in 
E. coli for genes that are required for DNA replication (Saito & Uchida, 1977; Yochem et 
al., 1978).  Later it was shown that DnaK and DnaJ are in the same genetic pathway and 
                                                 
1 Chapter 4 modified from an article accepted for publication by EMBO Journal (Jin Y, Awad W, Petrova 
K, and Hendershot LM, Regulated release of ERdj3 from unfolded proteins by BiP. EMBO J.  In press.). 
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 that DnaJ stimulates the ATPase activity of DnaK, thereby stabilizing the binding of 
DnaK to substrates (Liberek et al., 1991a).  As is the case with Hsp70s, DnaJ proteins are 
present in all organisms and all organelles, and the number of DnaJ proteins in an 
organism often exceeds the number of Hsp70 proteins present (Caplan et al., 1993; 
Cheetham & Caplan, 1998).  DnaJ proteins all possess a highly conserved ~70 amino 
acid “J” domain, which contains an invariant tripeptide sequence, His-Pro-Asp, that is 
required to interact with the ATP-bound form Hsp70 proteins (Mayer et al., 1999).  Like 
Hsp70 proteins, at least some DnaJ proteins can bind directly to unfolded substrates 
(Cheetham et al., 1998; Fan et al., 2003).  Peptide binding studies for E. coli DnaJ 
revealed significant overlap with the peptides that bound DnaK (Rudiger et al., 2001), 
arguing that DnaJ was likely to also bind to extended hydrophobic residues on unfolded 
proteins.  This possibility was supported by crystallographic data obtained for a peptide 
bound to the yeast cytosolic DnaJ protein, Ydj1 (Li et al., 2003).  The fact that DnaJs 
specifically interact with the ATP bound form of Hsp70s led to a model (Walter & 
Blobel, 1983; Mayer et al., 1999) where DnaJ proteins would bind first to unfolded 
proteins, recruit the ATP-bound or “open” form of Hsp70 to the substrate, and then 
stimulate its ATPase activity to “close” it onto the substrate more stably.  This model was 
supported by data showing that a cytosolic DnaJ protein bound to nascent chains 
extruding from the ribosome before the Hsp70 protein did (Hendrick et al., 1993), and by 
in vitro binding studies with DnaK, DnaJ, and denatured luciferase (Szabo et al., 1994).  
However, these studies did not reveal how DnaJ proteins were released from the 
substrate.  Unlike Hsp70, DnaJ proteins do not bind to nucleotide and have not been 
demonstrated to exist in different conformational states. 
 
The mammalian ER possesses at least six DnaJ family members (Brightman et al., 
1995; Meyer et al., 2000; Tyedmers et al., 2000; Yu et al., 2000; Shen et al., 2002; 
Cunnea et al., 2003; Rutkowski et al., 2007; Petrova et al., 2008).  One of these, ERdj3, 
was shown previously by our group to bind to a number of unfolded proteins in the ER 
that were BiP substrates (Shen and Hendershot, 2005).  When the binding of wild-type 
and mutant (HPD→QPD) ERdj3 to several different substrates was compared, we 
consistently found that mutant ERdj3 bound quantitatively better and longer than wild-
type ERdj3 (Shen et al., 2005).  The present study was undertaken to better understand 
the requirements for releasing DnaJ proteins from substrates.  Using a series of ERdj3 
and BiP mutants, we found that release of ERdj3 was not simply due to a competition or 
exchange with BiP, but that a functional interaction between ERdj3 and BiP was 
required.  We hypothesize that in addition to the ERdj3-induced conformational change 
that occurs in BiP, which stabilizes BiP’s binding to the unfolded protein, that there is a 
reciprocal change in the conformation of ERdj3 that triggers its release from substrate. 
 
4.2 Materials and Methods 
 
4.2.1 Cell culture, transfection, and immunoprecipitation 
COS-1 monkey kidney fibroblast cells were maintained in DMEM supplemented 
with 10% fetal bovine serum, 2mM L-glutamine, and 1% Fungisone in 3% CO2.  Cells 
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 were transfected with the indicated vectors using the Fugene 6 transfection reagent 
(Roche Diagnostics), and after forty-eight hours post-transfection, cells were labeled with 
35S Translabel (Amersham Biosciences) for 3h.  Cells were treated with 150 μg/ml 3,3’-
dithio-bis (propionic acid N-hydroxysuccinimide ester) (DSP), a membrane permeable 
cross-linking reagent (Sigma-Aldrich) for 1h on ice.  Cell lysates were prepared using an 
NP40 lysing buffer and immunoprecipitated with indicated antisera followed by binding 
to Protein A Sepharose beads.  The immunoprecipitated complexes were analyzed by 
SDS-PAGE under reducing conditions, and the signal was detected using Amplify 
(Amersham Bioscience) for radiographic visualization. 
 
4.2.2 In vitro translation and heavy chain binding assay 
Ag8.8 murine plasmacytoma cells were maintained in RPMI 1640 supplemented 
with 10% fetal bovine serum, 2mM L-glutamine, and 1% Fungizone in 5% CO2.  Cells 
were metabolically labeled for 16h with 35S Translabel (Amersham Biosciences) and 
treated with or without DSP prior to lysing.  Cell lysates were prepared and Ig heavy 
chains were isolated by binding to Protein A as described previously (Wei et al., 1995).  
To release BiP from heavy chains, non-cross-linked samples were supplemented with 1 
mM MgCl2, 25 mM KCl, and 1 mM ATP.  These samples are the source of free HC used 
in the in vitro binding assays, except that the beads were washed an additional three times 
in PBS to reduce detergent in the samples, which interferes with the ability of ERdj3 to 
remain associated with unfolded substrates (Shen et al., 2005). 
 
The cDNAs encoding wild type and mutant (H35Q) ERdj3 were transcribed from 
the T7 promoter of 3HADSL-ERdj3 (Stratagene) and translated using 35S methionine 
(Amersham Biosciences) and the TNT coupled rabbit reticulocyte lysate (Promega).  
Equivalent counts for the two protein products were loaded directly on reducing SDS-
polyacrylamide gels or incubated with either uncoupled Protein A Sepharose beads 
(washed three times in PBS), or with the Protein A Sepharose beads to which free γHC 
were bound.  After incubating for 1h on ice, the beads were washed three times with PBS 
and bound proteins were subjected to reducing SDS-PAGE. 
 
4.2.3 IP western 
Firefly luciferase (Promega) was left untreated (N) or heat denatured (D) at 42°C 
for 1h.  In both cases, 0.5 μg of protein was incubated with recombinant wild type ERdj3 
protein (2.0μg) in PBS and immunoprecipitated with either anti-ERdj3 polyclonal 
antiserum followed by protein A Sepharose beads or with protein A Sepharose beads 
alone.  Bound proteins were subjected to reducing SDS-PAGE and then transferred to a 
PVDF membrane (BIO-RAD), which was blotted with an anti-luciferase antiserum 
(1:1000) (Promega).  Donkey anti-goat Ig conjugated to HRP (1:5000) was used as a 
secondary antibody and the signal was detected by chemiluminescence (ECL). 
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 4.2.4 Protein purification 
Expression of His-tagged wild-type and mutants ERdj3 was induced in E. coli M15 
cells with 0.1 mM isopropyl β-D-thiogalactoside (Sigma) followed by growth for 18 h at 
18°C.  The recombinant proteins were purified on  Ni2+-agarose columns under non-
denaturing conditions (Qiagen QIAexpress system), dialyzed in 25mM sodium phosphate 
buffer (pH 7.0), containing 150mM NaCl, 0.02% Triton X-100, 50% glycerol, and a 
protease inhibitor cocktail (Roche), and stored at -20°C.  His-tagged wild-type and 
mutant BiP proteins were induced with 1 mM IPTG for 2h at 37°C, purified on Ni2+-
agarose columns, dialyzed and stored in 20mM HEPES buffer (pH 7.2) with 50mM KCl, 
5mM MgCl2, 0.01% NP-40, 50% glycerol, and a protease inhibitor cocktail. 
 
4.2.5 Measurement of complex formation between ERdj3 proteins and denatured 
luciferase 
Firefly luciferase was denatured in buffer containing 7M Urea, 25mM HEPES (pH 
7.5), 50mM KCl, 5mM EDTA, 5mM MgCl2 and 5mM dithiothreitol at room temperature 
for 40 min and then diluted into PBS containing 0.05% BSA (final concentration 0.5 
µg/ml).  100 µl of this solution was added into each well of a 96-well microtiter plate 
purchased from Theromo (Immulon 2HB Flat Bottom Microtiter Plate) and allowed to 
bind overnight at 4ºC.  Wells were washed with PBS and blocked with 200 μl PBS 
containing 1% BSA for 1h at room temperature.  The indicated concentrations of wild 
type or mutant ERdj3 in 100 μl of PBS with 0.05% BSA was added to the wells and 
incubated for 1h at room temperature, followed by washing with PBS to remove 
unbounded ERdj3.  The amount of ERdj3 that remained bound to denatured luciferase 
was detected with a polyclonal anti-ERdj3 antiserum (Shen et al., 2005) followed by 
donkey anti-rabbit Ig conjugated to alkaline phosphatase (Promega).  4-Nitrophenyl 
phosphate disodium salt hexahydrate (Sigma) was added, and after stopping the reaction 
with 0.75 M NaCl, the plates were read on a spectrophotometer at wavelength 405nM.  
Negative controls were set up for each plate in wells that did not contain either denatured 
luciferase, ERdj3, or each of the antibodies, but which included all the other steps of the 
reaction.   
 
4.2.6 Release of ERdj3 from luciferase 
To detect the amount of BiP binding to denatured luciferase, recombinant hamster 
BiP was added to wells coated with denatured luciferase instead of ERdj3, and incubated 
as above, except that a rabbit polyclonal anti-rodent BiP antiserum was used to detect BiP 
binding.  To test the ability of wild-type and mutant BiP to release ERdj3 from luciferase, 
ERdj3 was first bound to luciferase as above.  After washing away unbound ERdj3, the 
indicated amounts of recombinant BiP proteins were added to the wells in PBS 
containing 1 mM MgCl2, 25 mM KCl and either 1 mM ATP or no nucleotide.  The plates 
were incubated for 1 hr at room temperature, and the amount of ERdj3 or BiP associated 
with the denatured luciferase was determined as above. 
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4.2.7 ATPase assay  
ATPase assays were performed as described previously (Chevalier et al., 1998).  
Briefly, 1µM of the various recombinant BiP proteins was incubated alone or with 0.5 
µM of the indicated full length ERdj3 proteins at 37°C for 20 min in ATPase buffer 
containing [-32P]ATP (PerkinElmer).  After chromatography, the radioactive ATP and 
free phosphate signals were quantified by phosphoimager analysis (Molecular Dynamics, 
Sunnyvale, CA) using Image Quant software.  The free phosphate signal was expressed 
as a percent of the total phosphate signal.  Data were deduced from three independent 
experiments, and the error bars represent standard deviations (S.D.). 
 
4.3 Results 
 
4.3.1 Comparison of the effects of J domain mutations on ERdj3’s ability to associate 
with substrate both in vivo and in vitro 
It has been shown that the J domains of DnaJ proteins are important for interactions 
with their Hsp70 partners, where the signature HPD motif in the J domain plays an 
indispensable role.  We previously demonstrated that a QPD mutation in ERdj3 
abrogated its ability to interact with its ER Hsp70 partner-BiP both physically and 
functionally (Shen et al., 2005).  To determine whether the interaction with BiP was 
crucial for ERdj3’s ability to bind to unfolded substrates, we examined the ability of 
wild-type and mutant ERdj3 to bind to immunoglobin heavy chain (γHC) both in vivo 
and in vitro.  First, we co-expressed γHC along with HA-tagged versions of either wild-
type ERdj3 or two different J domain mutants (both QPD and ∆ J) in COS cell.  Co-
immunoprecipitation experiments were performed on DSP-cross-linked cell lysates.  We 
found that J domain mutations did not negatively affect the ability of the mutant ERdj3 
proteins to bind to γHC in vivo (Figure 4-1A).  In fact, in both cases there was actually 
more binding of the QPD and ΔJ mutants to the γHC as compared to the binding of wild-
type ERdj3.  Wild type and mutant ERdj3 proteins were also expressed in COS cells 
alone.  Protein A Sepharose beads did not precipitate any of three proteins (Figure B-1) 
demonstrating that the binding observed in Figure 4-1A is dependent on the co-
expression of γHC.  These data suggested two things; first, since these mutants are unable 
to interact with BiP, ERdj3 might bind directly to unfolded substrates, and second these 
ERdj3 mutants might have a higher affinity for substrate or some component of the ER 
chaperone complex (Meunier et al., 2002).  To directly test the first possibility, we 
developed an in vitro assay to examine the binding of ERdj3 to γHC in the absence of 
other resident ER chaperones and folding enzymes.  It was based on our previous 
demonstration that BiP can be released from isolated HC in vitro with ATP leaving the 
HC in a conformation that allows them to reassociate with exogenously added BiP (Wei 
et al., 1995).  As shown in Figure 4-1B (lane 1), ERdj3 can be isolated with γHC only 
when cells are pretreated with a membrane permeable crosslinker, DSP, whereas BiP’s 
association with γHC is detectable even without crosslinking (Figure 4-1B, lane3).  
However, addition of ATP releases BiP from the γHC (Figure 4-1B, lane2).  These free 
HC were used for binding to in vitro translated ERdj3 proteins (Figure 4-1C).  We found 
  
 
Figure 4-1. ERdj3 binds to HC directly 
(A) Cos cells were co-transfected with cDNAs encoding  HC and the indicated HA-
tagged ERdj3 constructs.  Metabolically labeled, cross-linked cell lysates were 
immunoprecipitated with anti-HA or Protein A Sepharose alone.  Isolated proteins were 
separated by reducing SDS-PAGE.  (B) Ag8.8 cells were metabolically labeled for 16h 
with 35S methionine and cysteine and incubated with (lane 1) or without (lanes 2 and 3) 
DSP.  Cell lysates were prepared with (lane 2) or without (lanes 1 and 3) ATP and 
immunoprecipitated with Protein A Sepharose.  (C) Wild-type (WT) and QPD mutant 
(Mut) ERdj3 were in vitro translated and run directly (lanes 6 and 7) or incubated with 
the free  HC immobilized on protein A Sepharose beads prepared as in lane 2 in Figure 
4-1B (lanes 2 and 3) or with protein A beads alone (lanes 4 and 5). 
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 that unlike the in vivo binding assays, the QPD mutant bound to γHC at similar levels as 
observed for wild-type ERdj3 (Figure 4-1C, lanes 4 and 5).  These data revealed that 
ERdj3 associates directly with substrates and also argues that the enhanced binding of 
ERdj3 mutants to γHC in vivo is unlikely to be due to their having a higher affinity for 
substrate.  Instead, it suggested that something else in the cell might be contributing to 
the difference between wild-type and mutant ERdj3’s association with substrate.  Based 
on our previous data showing that mutant ERdj3 remains bound to unfolded Ig light 
chains much longer than wild-type ERdj3 (Shen et al., 2005), we hypothesized that the J 
domain mutations might be affecting release of the ER DnaJ proteins from substrates and 
that release might be dependent on a functional interaction with BiP. 
 
4.3.2 Development of an in vitro system to detect binding and release of ERdj3 from 
substrates 
Because the isolation of free HC was somewhat cumbersome, we wished to 
develop a simpler in vitro binding assay.  We chose denatured firefly luciferase (D-Luc), 
because it has been widely used as an in vitro substrate for other DnaJ family members, 
including E. coli DnaJ and two yeast cytosolic DnaJ family members Sis1 and Ydj1 
(Szabo et al., 1994;  Schumacher et al., 1996; Lu & Cyr, 1998a; Lu & Cyr, 1998b).  To 
determine if denatured luciferase could serve as an ERdj3 substrate in vitro, we examined 
the ability of wild-type ERdj3 to bind to either native or heat denatured luciferase in 
solution.  For these experiments we denatured luciferase with heat instead of urea, 
because we did not want to interfere with the protein: protein interactions required for 
association and for immunoprecipitation.  ERdj3 was allowed to interact with native or 
denatured luciferase and the samples were immunoprecipitated with either a polyclonal 
anti-ERdj3 antiserum or Protein A Sepharose beads.The association of luciferase was 
determined by immunoblotting with an anti-luciferase antibody.  We found that indeed 
the binding of ERdj3 to denatured luciferase (D) was readily detectable, whereas its 
binding to native luciferase (N) was below the level of detection (Figure 4-2A).  This 
distinction in binding is in keeping with ERdj3 acting as a chaperone and demonstrated 
that denatured luciferase could be used as an in vitro substrate for ERdj3. 
  
Next a modified ELISA was developed, which would allow us to readily examine 
the ability of ERdj3 to bind to luciferase under multiple conditions.  For this assay, the 
luciferase was chemically denatured, as has been done in a number of other studies 
(Szabo et al., 1994; Lu et al., 1998a).  First, we tested the binding of wild-type ERdj3 and 
the QPD mutant to chemically denatured luciferase which was bound to 96-well plates.  
Similar to the in vitro binding of these proteins to γHC, we found that both wild-type 
ERdj3 and the QPD mutant associated with chemically denatured luciferase equally 
(Figure 4-2B).  Thus, mutation of HPD sequence to QPD did not affect the binding of 
ERdj3 to chemically denatured luciferase. 
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Figure 4-2. WT and QPD ERdj3 bind to denatured luciferase similarly in vitro 
(A)Temperature denatured (D) or native (N) luciferase (Luc) was incubated with 
recombinant wild type ERdj3 protein and then immunoprecipitated with either anti-
ERdj3 polyclonal antiserum or with protein A Sepharose beads alone.  Reaction cocktails 
were subjected to reducing SDS-PAGE and then transfer to a PVDF membrane.  The 
membrane was blotted with goat anti-luciferase antiserum followed by donkey anti-goat 
Ig conjugated to HRP.  The signal was detected by chemilluminesence.  (B) Chemically 
denatured luciferase (grey bars) or binding buffer alone (hatched bars) was used to coat 
96-well plates.  After washing and blocking with 1% BSA, recombinant wild-type or the 
QPD mutant ERdj3 proteins (0.5 µM) were added to the wells and incubated for 1 hr at 
RT.  After washing, bound ERdj3 was detected with a polyclonal anti-ERdj3 antiserum, 
followed by donkey anti-rabbit Ig conjugated to alkaline phosphatase.  The DNTP 
substrate was added and after developing, the plates were read on a spectrophotometer 
and the signal was expressed in OD units.  A luciferase coated well that did not receive 
ERdj3 protein was treated similarly and serves as a negative control for the antibody 
(dark grey).  All samples were run in triplicate and error bars are indicated.
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 4.3.3 ATP does not affect the binding of wild type ERdj3 or the QPD and HPN 
mutants to substrate in vitro 
Before testing our hypothesis that ERdj3 release from substrates occurs in response 
to a functional interaction with BiP, it was necessary to set up an assay to saturate the 
binding of ERdj3 to luciferase and to ensure that incubation with ATP did not affect this 
binding.  Increasing concentrations of wild-type (Figure 4-3A), QPD (Figure 4-3B), or 
HPN (Figure 4-3C) recombinant ERdj3 proteins were added to luciferase coated wells in 
the absence (Figure 4-3 solid bar) or presence (Figure 4-3 stippled bar) of ATP.  We 
found that all three proteins reached saturation binding at concentrations of~500nM and 
that the inclusion of ATP in the binding buffer did not affect ERdj3’s ability to bind to 
substrate.  Thus, in the following experiments 500 nM ERdj3 was used. 
 
4.3.4 BiP promoted the release of wild-type ERdj3 from chemically denatured 
luciferase in the presence of ATP 
If a functional interaction between BiP and ERdj3 is critical for releasing ERdj3 
from substrates, the amount of ERdj3 that is associated with substrate is expected to 
decrease in the presence of BiP in an ATP-dependent manner.  To examine this 
possibility, increasing amounts of BiP were added to wells containing ERdj3 bound to 
denatured luciferase in the absence and presence of ATP (Figure 4-4A).  We found that 
the addition of increasing amounts of BiP in the absence of ATP did not affect ERdj3’s 
association with denatured luciferase (Figure 4-4A, solid bar), although there was a 
detectable increase in the binding of BiP to the substrate (Figure 4-4B, solid bar).  This 
demonstrates that release of ERdj3 does not occur via a simple competition between 
these two chaperones for substrate and further suggests that BiP and ERdj3 binding sites 
are not completely overlapping.  However, when ATP was included with BiP, we found 
that the ability of BiP to release ERdj3 was dependent not only on the concentration of 
BiP, but also required ATP (Figure 4-4A stippled bar).  The binding of BiP to denatured 
luciferase did not increase (Figure 4-4B stippled) when ERdj3 was released (Figure 4-4A 
stippled bar), again suggesting that ERdj3 release does not occur due to a simple 
competition with BiP.  To examine this from the other direction, we first bound either 
wild-type BiP or a BiP mutant that cannot interact with ER DnaJ proteins (R197H) 
(Awad et al., 2008) to denatured luciferase and measured the ability of ERdj3 to release 
them.  We found that the addition of ERdj3 did not induce a reduction in the binding of 
either wild-type or mutant BiP to luciferase coated well (Figure 4-4C solid and stippled 
bars), even though we could readily measure the binding of ERdj3 to luciferase (Figure 
4-4C checkered bars).  This further argues that the release of ERdj3 does not occur due to 
a simple competition between BiP and ERdj3 for binding sites on the substrate.  
 
4.3.5 BiP mutants that do not interact with ERdj3 failed to promote the release of 
ERdj3 from substrate 
The requirement of ATP for BiP to release ERdj3 from the substrate suggested that 
a functional interaction between BiP and ERdj3 might be necessary.  To test this 
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Figure 4-3. WT and mutant (QPD and HPN) ERdj3 bind to D-Luc similarly and 
ATP does not affect their binding 
Chemically denatured luciferase was used to coat the wells and the indicated amounts of 
WT (A) QPD (B) or HPN (C) ERdj3 were added to the wells with (stippled bar) or 
without (solid bar) ATP.  The plates were developed with anti-ERdj3 as described in 
Figure 4-2.  The arrow indicates the concentration of ERdj3 that was used in the 
following experiments. 
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Figure 4-4. BiP releases ERdj3 from D-Luc in an ATP-dependent manner 
(A) Chemically denatured luciferase was added to the wells followed by ERdj3 binding 
as described previously.  After washing, the indicated amounts WT BiP were added to the 
ERdj3:luciferase complexes with (stippled bar) or without (solid bar) ATP and incubated 
for an additional 1hr at room temperature.  After washing, the amount of ERdj3 that 
remained bound to luciferase was detected with an anti-ERdj3 antiserum.  (B) On a 
parallel plate the amount of BiP that was associated with luciferase was determined by 
incubating with an anti-BiP antiserum.  (C) Either wild-type or mutant (R197H) BiP was 
allowed to bind to luciferase.  After washing, ERdj3 was added to half the wells and the 
amount of BiP that was bound without ERdj3 (solid bars) or with ERdj3 (stippled bars) 
was measured with an anti-BiP antiserum.  In a parallel set of wells, ERdj3 binding was 
measured with an anti-ERdj3 antibody (checkered bars).
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 possibility, we examined the ability of a number of different BiP mutants to release 
ERdj3 from luciferase.  A highly conserved arginine on the ATPase domain of Hsp70 
proteins (R197 in BiP) has been shown to be essential for interaction with the HPD motif 
on DnaJ proteins (Gassler et al., 1998; Suh et al., 1998; Alder et al., 2005).  We recently 
made three substitutions at this site (R197H, R197A, and R197E), all of which have 
ATPase activity equal to or greater than wild-type BiP, but none of them can bind or be 
further stimulated by J proteins (Awad et al., 2008).  Two other BiP mutants were also 
tested; a G227D mutant that cannot bind to ATP and a T37G mutant that cannot undergo 
the ATP-induced conformational change that is required for its chaperoning activity (Wei 
et al., 1995).  Recombinant proteins corresponding to each of these mutants were made 
and tested both for their ability to bind to luciferase and to release wild-type ERdj3.  We 
found that all five BiP mutants were able to bind equivalently to luciferase when tested at 
a concentration of 50 µM (Figure 4-5A), whereas only very low levels of background 
binding to the wells were observed for all of these proteins when luciferase was not 
present (Figure B-2).  Although all of the mutants bound to luciferase both alone and in 
the presence of ERdj3 (Figure 4-5C), none of them was able to release ERdj3 from this 
substrate even in the presence of ATP (Figure 4-5B). 
 
4.3.6 Wild type BiP does not release two ERdj3 mutants, QPD and HPN, from 
luciferase 
To further explore the possibility that a functional interaction between ERdj3 and 
BiP was required for ERdj3 release, we produced two ERdj3 proteins in which the HPD 
motif had been mutated and therefore should not interact functionally with wild-type BiP 
based on previously defined DnaJ mutants (Wall et al., 1994).  The first of these, 
HPD→QPD, disrupts binding to BiP and stimulation of its ATPase activity without 
interfering with the ability of this mutant to bind to substrates (Shen et al., 2005).  The 
second mutant HPD→HPN corresponds to a DnaJ mutant that was defective in 
interacting with wild-type DnaK (Suh et al., 1998).  We first tested the ability of these 
two mutants to bind to BiP in vivo and to stimulate its ATPase activity in vitro.  Wild-
type and mutant ERdj3 proteins were co-expressed in COS cells with BiP.  Forty-eight hr 
post-transfection metabolically labeled cells were incubated with DSP to cross-link 
proteins and cell lysates were immunoprecipitated with either anti-BiP or anti-ERdj3 
polyclonal antiserum (Figure 4-6A).  We found that both mutations interfered with the 
ability of ERdj3 to bind to BiP, which is in keeping with data from a number of other 
DnaJ family members (Tsai & Douglas, 1996; Kelley & Georgopoulos, 1997; Wittung-
Stafshede et al., 2003).  Recombinant full-length proteins corresponding to these mutants 
were produced, and their ability to stimulate the ATPase activity of BiP was compared to 
that of wild-type ERdj3.  We found that wild-type ERdj3 stimulated BiP’s ATPase 
activity about 2-fold, which is in keeping with previous data obtained with only the J 
domain and glycine/phenylalanine regions of ERdj3 (Shen et al., 2005), whereas the 
HPN and QPD mutants were unable to appreciably increase the hydrolysis of ATP 
(Figure 4-6B). 
 
We next performed an experiment similar to those described in Figures 4-4 and    
4-5, except that this time we were asking if wild-type BiP was only capable of releasing
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Figure 4-5. Only WT BiP releases ERdj3 from D-Luc 
(A) Chemically denatured luciferase was added to the wells, which were then incubated 
with wild-type or mutant BiP.  The binding of BiP to D-Luc was performed in the 
absence of ERdj3 and detected with anti-BiP serum.  (B and C) Denatured luciferase was 
added to wells and wild-type ERdj3 was allowed to bind as described.  After washing, 
either wild-type or mutant BiP was added with (stippled bars) or without (solid bars) ATP.  
The amount of ERdj3 remaining was detected with an anti-ERdj3 antiserum (B) and the 
binding of BiP was detected with an anti-BiP antiserum (C) and expressed in O.D. units.
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Figure 4-6. Wild-type BiP can only release wild-type ERdj3 from D-Luc 
(A) Cos cells were co-transfected with wild-type BiP and the indicated ERdj3 vectors.  
DSP-cross-linked cell lysates were immunoprecipitated with anti-BiP or anti-ERdj3 and 
analyzed by reducing SDS-PAGE.  (B) ATPase assays were performed on wild-type BiP 
alone or with a 4-fold molar excess of wild-type, HPN, or QPD ERdj3.  ATP hydrolysis 
was measured by quantitating ADP and expressing it as a percent of total nucleotide.  (C) 
An experiment similar to that described in the previous figure was performed, except that 
either wild-type or mutant ERdj3 was bound to luciferase first.  After washing, wild-type 
BiP was added with (stippled bars) or without (solid bars) ATP.  The amount of ERdj3 
that remained bound was detected with an anti-ERdj3 antiserum and expressed in O.D. 
units. 
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 wild-type ERdj3 or if it was also able to release the two ERdj3 mutants that did not 
functionally interact with BiP.  If BiP released the ERdj3 mutants, it would argue that a 
functional BiP/ATP/substrate interaction was required but that there was no need for a 
functional BiP/ERdj3 interaction.  We found that only wild ERdj3 was released by wild 
type BiP in the presence of ATP, whereas both the QPD and HPN mutants remained 
bound to the substrate even in the presence of ATP (Figure 4-6C).  The combination of 
this experiment and the previous one (Figure 4-5A) demonstrate that both a 
BiP/ATP/substrate interaction and a functional BiP/ERdj3 interaction are required to 
release ERdj3 from substrate.  
 
In a search for allele specific suppressors of DnaJ HPN and QPD mutants, no 
suppressors were found for the QPD mutant, but three different DnaK mutants were 
identified that restored growth at temperatures that were non-permissive for the HPN  
mutant (Suh et al., 1998).  Of these, the DnaK R167H mutant (analogous to our R197H 
mutant) bound better than wild-type DnaK to the DnaJ HPN mutant.  Thus, we wished to 
determine if our HPN ERdj3 mutant and our R197H BiP mutant would constitute a 
functional pair that could rescue the inability of HPN ERdj3 to be released from 
substrate.  To determine this, we first measured the ability of both the QPD and HPN 
mutants to bind to and stimulate the ATPase activity of R197H BiP, which cannot be 
stimulated with wild-type ERdj3 (Awad et al., 2008).  Wild-type and mutant ERdj3 
proteins were co-expressed in COS cells with R197H BiP as described above.  We found 
that the HPN mutant was as defective in binding to R197H BiP mutant as either wild-
type ERdj3 or the QPD mutant (Figure 4-7A).  Thus, unfortunately the HPN ERdj3 
mutant did not appear to re-establish a functional pair with the R197H BiP mutant by this 
criterion.  We also examined the ability of the various ERdj3 proteins to stimulate the 
ATPase activity of R197H BiP, and found that only the HPN mutant showed a very 
modest ability to stimulate the ATPase activity of R197H BiP (Figure 4-7B).  However, 
this weak stimulation is not comparable to the stimulation of WT ERdj3/ BiP pair.  This 
result is consistent with our in vivo binding data showing that HPN ERdj3 did not bind 
detectably to R197H BiP, and suggested that the HPN ERdj3/R197H BiP pair did not 
reform a functional pair as observed for the corresponding mutants in DnaJ and DnaK. 
 
However, since two of the DnaK allele-specific suppressors of the HPN DnaJ 
mutant did not bind better to HPN DnaJ than wild-type DnaK (Suh et al., 1998), we 
proceeded to determine if our R197H BiP mutant could release the HPN ERdj3 mutant 
from denatured luciferase.  We found that R197H BiP was unable to release either the 
wild type or the QPD ERdj3 mutant (Figure 4-7C), which is in keeping with the fact that 
no allele specific suppressors were found for the DnaJ QPD mutant (Suh et al., 1998).  
However, when we examined the interaction between the R197H BiP mutant and the 
HPN ERdj3 mutant we observed a very small but reproducible release of the HPN ERdj3 
mutant.  The amount of release was greater than that observed when wild-type BiP was 
used to release the HPN mutant but nowhere near that achieved when the wild-type form 
of each protein was used.  This suggests that the R197H BiP/HPN ERdj3 proteins do not 
constitute a fully functional pair but do possess a small amount of activity together. 
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Figure 4-7. R197H BiP cannot be released from D-Luc by either wild-type ERdj3 
or the QPD mutant 
The experiments were performed exactly the same as in Figure 4-6 except that the R197H 
BiP mutant was used to release the various ERdj3 proteins. 
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 4.4 Discussion 
The vast group of proteins that comprise the DnaJ-like family has been subdivided 
into three subclasses (Cheetham et al., 1998).  The type I and type II proteins bind a 
broad spectrum of substrates, whereas the type III protein, which possess only a J domain 
that can be found anywhere in the protein, either are not known to interact directly with 
substrates or in some cases bind to a much more restricted subset of proteins.  There is 
now a significant amount of data to argue that DnaJ proteins bind to unfolded proteins 
initially and due to their ability to interact specifically with the ATP form of Hsp70s 
serve to recruit the open form of the Hsp70 to the substrate.  Hsp70 proteins must be able 
to interact with a DnaJ protein as well as to bind and hydrolyze ATP in order to be 
efficiently recruited to the substrate (Wawrzynow et al., 1995).  Data showing that DnaJ 
proteins can interact with the SBD of the Hsp70 as well as with its NBD have led 
investigators to speculate that this might allow the DnaJ protein to deliver and transfer the 
substrate to the correct region of the Hsp70 protein (Laufen et al., 1999).  Several models 
have been proposed as to how this may occur.  First, it is possible that once the DnaJ 
protein contacts an Hsp70, it releases the unfolded protein and the Hsp70 captures it 
(Rudiger et al., 2001).  The identification of stable DnaJ/Hsp70/substrate complexes 
(Szabo et al., 1994; Wawrzynow et al., 1995; Han & Christen, 2003; Shen et al., 2005;) 
makes this scenario less likely.  Second, it has been proposed that the two proteins bind 
distinct sequences on the substrate, which is supported by the identification of binding 
sites on substrate proteins for DnaK and DnaJ using peptide libraries (Kim et al., 2002; 
Han et al., 2003).  Once the J domain interacts with the NBD of the Hsp70, it has been 
argued that this would reorient the Hsp70 and in some way wrench the substrate from the 
DnaJ protein (Landry, 2003).  Our demonstration that wild-type BiP, which binds the 
substrate but cannot release the QPD or HPN mutant could be interpreted as being 
compatible with this model, since the absence of the BiP/ERdj3 interaction might not 
allow BiP to wrench the substrate from ERdj3.  This wrenching would need to happen 
before ATP is hydrolyzed, as DnaJ domains lose affinity for the ADP bound form of 
Hsp70 (Wawrzynow & Zylicz, 1995) and maximal stimulation of the ATPase activity of 
Hsp70s by DnaJs only occurs after the substrate binds to the Hsp70 (Laufen et al., 1999).  
Finally, it is possible that in addition to the conformational change that DnaJ induces in 
the Hsp70 protein, that after substrate binding and ATP hydrolysis the Hsp70 protein 
causes a reciprocal conformational change in the substrate binding domain of the DnaJ 
protein.  It is known that DnaJ proteins have a second interaction site with the SBD of 
Hsp70s (Laufen et al., 1999), but it is not clear which domain of DnaJ is involved it this 
binding (Wall et al., 1995; Wawrzynow et al., 1995; Linke et al., 2003; Sahi & Craig, 
2007;) nor how alterations in these interactions affect the structure of DnaJ proteins.  Our 
data is also compatible with this model. 
 
Our discovery that the release of ERdj3 from substrate is dependent on a functional 
interaction with BiP is likely to be true of other DnaJ/Hsp70 pairs.  Recent data from 
Petrova et al., demonstrate a similar requirement for the release of another ER localized 
DnaJ protein, P58, from substrate.  In this study P58 was shown to bind directly to 
misfolded RNase A in vitro and was released from it by BiP in the presence of ATP and 
Mg2+.  Mutations in either P58 or BiP that disrupted the interaction between them 
blocked the release of P58 from misfolded RNase A.  In addition to interactions between 
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 the nucleotide binding domain of BiP and the ER localized DnaJ protein, this study 
further revealed that BiP also needed to bind to the substrate to trigger DnaJ release.  
Based on the conservation of interactions between other DnaJ/Hsp70 proteins, we believe 
this is likely to be a universal requirement for the release of DnaJs.  In support of this, an 
earlier in vitro study found that DnaJ bound to a substrate and prevented its aggregation, 
but it could not fold the protein unless DnaK and ATP were present (Lu & Cyr, 1998; 
Fan et al. 2005).  In view of our data, it is reasonable to suggest that DnaJ remained 
bound to the substrate in the absence of DnaK, thereby preventing its aggregation, but 
also preventing it from folding.  Only in the presence of ATP would both chaperones be 
released allowing the substrate to fold.  We would speculate, based on our data, that in 
the absence of ATP that both DnaK and DnaJ might bind, but folding would not occur. 
 
Our previous characterization of the interaction of ERdj3 with substrates in 
cultured cell lines revealed that wild-type ERdj3 disappeared from BiP:substrate 
complexes long before folding was complete, whereas a QPD mutant remained 
associated with the substrate (Shen et al., 2005).  This led us to speculate that the 
prolonged binding of the QPD mutant to substrates could be due to its inability to 
recognize that BiP had bound productively to the substrate.  The data presented here 
confirm that the release of ERdj3 from substrate, at least in vitro, required an interaction 
between the J domain of ERdj3 and NBD of BiP and argue that indeed this is the reason 
for prolonged association of mutant ERdj3 with substrates in vivo.  The in vitro release of 
ERdj3 from substrate also required BiP’s ATPase and substrate binding activity, as 
neither the T37G, G227D (this study), nor the NBD alone (Petrova et al., 2008) were able 
to release the corresponding DnaJ proteins from their substrates.  These requirements 
would ensure that once a DnaJ protein engages an unfolded substrate, it would remain 
bound to prevent aggregation until it had recruited an open form of Hsp70 to the 
substrate, allowed the Hsp70 to initially associate with the substrate and then hydrolyze 
ATP to form a more stable interaction.  Only when all of these steps had occurred would 
the DnaJ protein release from the Hsp70 and from the substrate.  This scenario is 
consistent with most published data showing that DnaJ proteins bind first and more 
transiently than Hsp70, which remain associated until folding is complete.   
 
In summary, our studies show that BiP promotes the release of ERdj3 from 
substrates in the presence of ATP.  This is not due to a competition for binding sites on 
the substrate once BiP is recruited through its association with ERdj3, but rather it 
requires a functional interaction between ERdj3 and BiP.  This includes both the ability 
to physically interact with each other as well as the ability of ERdj3 to stimulate the 
ATPase activity of BiP.  The fact that similar data was observed with another ERdj/BiP 
pair (Petrova et al., 2008) argues that this mechanism is likely to be used for the release 
of other DnaJ proteins from substrates. 
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CHAPTER 5. DISCUSSION 
 
Many DnaJ proteins can interact directly with unfolded substrates and prevent them 
from aggregating in vitro.  Crystallographic studies of the C-terminal peptide binding 
fragments of Ydj1 (Li et al., 2003) and Sis1 (Sha et al., 2000) determined the putative 
substrate binding of domain of DnaJ proteins.  The substrate binding characteristics of 
mammalian ER DnaJ proteins were poorly understood when I started my project.  Since 
ERdj3 interacts with unassembled Ig heavy chains unusually stably in vivo, it provided a 
good model to study the interaction between a mammalian DnaJ protein and an unfolded 
substrate.  In my first study (Chapter 2), we characterized the structural requirements for 
ERdj3 to bind to substrates by using a combination of in vivo and in vitro assays.  Our 
data indicates that hydrophobic amino acids in domain I of ERdj3 are conserved with 
those of Ydj1 and form a putative substrate binding site.  Comparison the structures of 
domain I of Ydj1 and Sis1 (Sha et al., 2000) suggests that Sis1 is likely to contain the 
same substrate binding site, even though Sis1 was crystallized without a bound peptide. 
Together these studies, coupled with mine, suggest that this substrate binding structure 
may be common to all type I and II DnaJ proteins.  Very recently a structure was solved 
for the putative peptide-binding fragment of Hdj1(Hu et al., 2008), a human type II DnaJ 
protein.  Like Sis1, this fragment was crystallized without a bound peptide, forms dimers, 
and has a very similar structure to Ydj1, except that it lacks a domain II.   
 
However, our data revealed that domain II of ERdj3 is also involved in substrate 
binding, which is not supported by the Ydj1 structure where the peptide only associated 
with domain I.  Since Ydj1 was co-crystallized with a small peptide (GWLYEIS), which 
is much smaller than natural substrates, it is possible that domain II cooperates with 
domain I to form a larger substrate binding site in cells allowing Ydj1 to interact with 
larger polypeptides (Figure 5-1A).  The other possibility is that domain II stabilizes the 
structure of domain I in the absence of substrate (Figure 5-1B), which is supported by the 
fact that Ydj1’s structure could only be solved in the presence of peptide.  To test this 
possibility, we attempted to co-express domain II of ERdj3 (PRSF-II) along with His-
tagged ERdj3-∆II in bacteria cells and use Ni2+-agarose columns to pull down the 
induced proteins.  If our hypothesis was correct, we expected that domain II would bind 
to the ERdj3-ΔII protein in trans and restore the ability of ERdj3-ΔII to bind to denatured 
luciferase in vitro.  Unfortunately, domain II is so small (about 40 amino acids) that it 
was not expressed at detectable levels.  It might be possible to solve this problem by 
adding a GST tag to domain II to make a larger protein which might allow it to be 
expressed more stably in bacteria.  However, the GST tag may affect the ability of 
domain II to interact with domain I and could be removed.  This could be done by 
inserting a cleavage site such as thrombin or factor Xa between the GST tag and domain 
II.  An alternative way to test whether domain II interacts with domain I to stabilize it 
would be to synthesize the domain II polypeptide in vitro.  This strategy may be possible 
since domain II only has 40 amino acids, which is within the range of what can be 
synthesized in vitro.  By adding domain II back to our binding assay with ERdj3-∆II, we 
could examine its ability to restore ERdj3-∆II binding to D-Luc. 
 
  
 
 
Figure 5-1. Potential roles of domain II is ERdj3 structure 
(A) cooperate with domain II to bind to substrate  (B) stabilize domain I in the absence of 
substrate.
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 NMR analyses might provide another tool to monitor the possibility that domain II 
interacts with domain I in the absence of peptide to stabilize this domain.  Since a 
structure has been solved for domains I, II, and III of Ydj1 coupled with peptide, the 
NMR study of Ydj1 instead of ERdj3 may be a more straightforward way to answer this 
question.  The size of Ydj1’s domain I is 79 amino acids and with domain II it is 144 
amino acids, which is well within the range for NMR studies.  Comparing the structures 
of a Ydj1 fragment that includes only domain I and II in both the presence and absence of 
peptide could give an answer.  If domain II binds to domain I in the absence of peptide, 
we would expect to see a change in the substrate binding face at domain I when peptide 
was added.  If domain II serves to provide a larger binding site for different substrates, 
we would expect to see no change in the substrate binding face in the presence or absence 
of peptide.   
 
It is important to note that type II DnaJ proteins (such as Sis1 and Hdj1), which 
lack domain II, can bind to substrates just fine.  It has been proposed recently, that 
domain I of type II DnaJ proteins may possess significant flexibility (Hu et al., 2008), 
which would allow them to adjust the size or shape of the substrate binding cleft.  It is 
possible that type I proteins achieve this additional flexibility through interactions 
between domain I and II.  It is also very likely that type I and II DnaJ proteins have 
different substrate specificities that require different structures.  However, 
complementation studies with different DnaJ proteins argue that in most cases these 
substrates must but not be essential ones. 
 
Although we decided that overall ERdj3 was structurally very similar to Ydj1, the 
four cysteine residues in domain II of ERdj3 form intra-domain disulfide bonds, whereas 
the eight cysteines in Ydj1 form two zinc binding sites.  Since Ydj1 and ERdj3 belong to 
different organisms and exist in different organelles, it was expected that they might not 
be interchangeable.  Ydj1 expressed in the ER would not bind zinc atoms, and ERdj3 
expressed in the cytosol was unlikely to form disulfide bonds.  This led us to speculate 
that verification of the role of domain II of ERdj3 in substrate interaction would be 
possible by creating chimera proteins made up of various combinations of ERdj3 and 
Ydj1 domains.  The fact that ER expressed Ydj1 can interact with BiP and ERdj3 
substrate (Figure 4-2) denied that strategy but led to studies described in Chapter 3.  In 
this study, we found that ERdj3 could compensate the loss of Ydj1 and that both the 
ability to stimulate the ATPase activity of the Hsp70 partner and to bind to substrates 
were necessary for ERdj3 to compensate for the loss of Ydj1.  Because domain II seems 
to be important for ERdj3’s substrate binding function and the intra-domain disulfide 
bonds were reported to be critical for substrate binding in vitro, we discussed the three 
possibilities in Chapter 3 to account for this.  First, we argued that it is possible that the 
disulfide bonds do form in ERdj3 even in the relatively reducing environment of the 
cytosol.  Second, these cysteines may be in a reduced state in the yeast cytosol, but the 
formation of disulfide bonds might not be necessary for ERdj3’s function in vivo.  
Finally, we suggested that when ERdj3 is expressed in the yeast cytosol, it is possible that 
the cysteines in domain II of ERdj3 could bind to Zn2+, which would serve to bridge the 
four cysteines and might stabilize this domain by mimicking the conformational stability 
that disulfide bonds provide.  To verify whether ERdj3 forms disulfide bonds in the yeast 
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cytosol, we could express ERdj3 in yeast cells, isolate the protein and then subject it to 
reducing and nonreducing SDS-PAGE to check its migration (Figure 5-2).  If disulfide 
bonds form in the cytosol, we will find that ERdj3 migrates slower in reducing SDS-
PAGE than under non-reducing conditions (pattern #1).  If there is no change in the 
migration of the protein with the addition of reducing agents, it would mean either that 
disulfide bonds do not form (pattern #2) or that zinc is binding to the cysteines and is not 
removed by reducing agents in the sample buffer (pattern #3).  To distinguish between 
the second and third possibilities, we could compare their mobility to that of reduced and 
non-reduced ERdj3 isolated from mammalian cells.  If the ERdj3 expressed in yeast 
migrates with the reduced form of mammalian ERdj3, it would argue that no disulfide 
bonds form, whereas if it migrates faster than the reduced form, it might suggest that zinc 
is binding to these cysteines and holding domain II in a more compact form.  To test this 
possibility, we could treat the ERdj3 isolated from the yeast cytosol with ρ-
hydroxymercuripherysulfon which is sulfhydryl-dissociating reagent and was used to 
remove Zinc from DnaJ (Tang et al., 2001). 
 
Although it is fairly well understood how Hsp70 proteins are released from 
substrates, very little is known about how DnaJ proteins are released.  Our in vivo data 
showing that ERdj3 proteins that could not interact with BiP actually resulted in more 
ERdj3 being associated with the substrate (Chapter 2) led us to speculate that this might 
occur due to decreased release of ERdj3 from substrate and not due to increased binding.  
We hypothesized that a functional interaction between DnaJs and Hsp70s might be 
required to release DnaJ from substrates.  The development of an in vitro binding assay 
(Chapter 2) allowed me to test this.  Using a series of ERdj3 and BiP mutants with 
denatured luciferase as the substrate, we determined that release of ERdj3 required the 
ATPase activity of BiP and the ability of ERdj3 and BiP to interact.  To demonstrate the 
latter point, we used BiP mutants that could not bind to ERdj3 as well as ERdj3 mutants 
that could not bind to BiP.  We suggested that the interaction with BiP may induce a 
reciprocal change in ERdj3 that triggers its release from substrates (Chapter 4).  This 
allowed us to propose a general model for the release of DnaJ proteins from substrates 
(Figure 5-3).  However, we did not demonstrate that ERdj3 actually undergoes a 
conformational change in that study.  Protease sensitivity is a method that is often used to 
measure conformational changes.  It is tricky for our assay, since we would need to 
retrieve ERdj3 protein bound to substrate and BiP and compare it to released ERdj3.  We 
would expect there to be changes in protease sensitivity due to substrate binding that 
could not be easily distinguished from conformational changes in ERdj3 itself. 
Conformational changes can also be monitored by measuring changes in tryptophan 
fluorescence.  This assay has been used to monitor conformational changes in Hsp70 
proteins that occur in response to nucleotide binding.  This type of assay is dependent on 
the local environment of the tryptophan changing in response to a larger conformational 
change in the protein.  It is possible that this could be an alternative way to answer the 
question. Among the three proteins in our reaction, there are no tryptophan residues in 
luciferase, two in BiP (which would have to be mutated), and only one in ERdj3, which 
occurs in domain III. If no change is observed, we would probably need to engineer 
another tryptophan into another region of ERdj3, although it is not clear where the best 
  
 
Figure 5-2. Potential patterns of cytosolic ERdj3
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Figure 5-3. Model for dissociation of ERdj3 from substrate proteins 
ERdj3 binds directly to substrates and recruits the ATP bound form of BiP.  A transient 
3-way complex is formed.  ERdj3 activates the ATPase activity of BiP, which decreases 
the affinity of ERdj3 for BiP (step 1) and induces a conformational change in the 
substrate binding domain of BiP, which stabilizes its binding substrate (step 2).  We 
hypothesis that this interaction triggers a reciprocal conformational change in ERdj3 that 
decreases its affinity for substrate (step 3), allowing it to dissociate.  
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 place to put the tryptophan would be.  Alternatively, it might be necessary to switch to 
another DnaJ protein. 
 
A separate limitation of our study (Chapter 4) was that all of our BiP ATPase 
mutants were also defective in binding to ERdj3, which made it impossible to separate 
which defect led to an inability to release ERdj3 from substrate.  A recent paper reported 
that the E175S Hsc70 mutant has a very low ATPase activity but is still able to bind to 
DnaJ proteins (Jiang et al., 2007).  Our lab had previously produced the corresponding 
point mutation in hamster BiP (E201G) and reported that it has very low ATPase activity, 
but still can bind ATP and substrate (Gaut & Hendershot, 1993).  If this BiP mutant 
behaves the same as the E175S Hsc70 mutant and is able to interact with ERdj3, we 
could use it in our release assay to examine whether both the ATPase activity and binding 
to ERdj3 are required or if only the binding to ERdj3 is sufficient for its release.   
 
In conclusion, our studies characterized the structural requirements for ERdj3’s 
ability to bind to substrates and further determined the requirements for producing 
functional Hsp70-DnaJ pairs.  In addition, my studies provided further insights on the 
mechanism used to release ERdj3 from substrates.  The fact that Hsp70s and DnaJ 
proteins are so well conserved suggests that our findings have general implications for 
Hsp70-DnaJ pairs.  Hopefully our data will encourage others to further explore these 
possibilities.
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Figure A-1. Schematic drawings of the domain structure of Ydj1, Scj1 and ERdj3 
According to Ydj1’s crystal structure, domain II is intercepted in domain I and separates 
it into two halves: Ia and Ib, which fold together to form the intact substrate binding site. 
Scj1 is a type I DnaJ protein in yeast ER.  It is predicted to have the similar structure as 
Ydj1 except the N-terminus ER signal sequence, which is cleaved from the mature 
protein.  ERdj3 is considered to be a type I DnaJ protein also, although it contains a 
smaller domain II.  light blue: ER signal sequence; black: J domain; yellow: G/F; red: 
domain I; green: domain II; blue: domain III.
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Figure A-2. Expression of Ydj1 in mammalian ER 
Two ER targeting form of Ydj1 were expressed in COS-1 cells that had been grown on 
coverslips.  ssYdj1 has an ER signal sequence engineered at it N-terminus, and ssYdj1 
C406S was generated by adding the N-terminus signal sequence and removing the C-
terminus farnesylation site.  Both are constructed in the 3HA-DSL vector and have C-
terminus HA-tag.  Cells were fixed and stained with an anti-HA antibody followed by 
FITC goat-anti-mouse IgG.  Grp94, an abundant ER luminal protein that served as 
control for ER localization, was detected with an anti-Grp94 antiserum followed by 
TRITC conjugated goat-anti-rabbit IgG.
     85
  
 
Figure A-3. Expression of the various wild-type and mutant ERdj3 in yeast 
Wild-type HLJ1YDJ1 (A) and mutant hlj1Δydj1-151 (B) yeast strains containing an 
empty vector (-), or expression vectors for an ER-targeted form of ERdj3 (ssERdj3), an 
ER-tethered cytosolically localized form of full-length ERdj3 (CaaX) or CaaX mutants 
(CaaX-ΔII-GSGG, CaaX-F326D, CaaX-I134A, CaaX-L208A and CaaX-IVLFa) were 
immunostained with antibodies against ER-lumenal Kar2p (TRITC labeled secondary 
antibody) and ERdj3 (FITC labeled secondary antibody).  DAPI was used to visualize the 
nuclear DNA. 
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Figure B-1. WT/∆J ERdj3 do not bind to Protein A Sepharose beads by 
themselves 
Cos-1 cells were transfected with cDNAs encoding HA-tagged versions of wild type 
ERdj3, a mutant that lacked the J domain (∆J) or one that had a mutation which disrupted 
the BiP interaction site (HPD→ QPD).  Forty hours post-transfection, cells were 
metabolically labeled for 3hrs and treated with DSP as in Figure 4-1.  After quenching, 
cell lysates were made and immunoprecipitated with either anti-HA or Protein A 
Sepharose alone.  Isolated proteins were separated by reducing SDS-PAGE.
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Figure B-2. Neither WT nor mutants BiP bind non-specifically to BSA blocked 
wells 
Plate ELISA assays were performed as in Figure 4-4 except that denatured luciferase was 
not used to coat the wells.  Briefly, 200 μl of PBS containing 1% BSA was added to 
block the wells and incubate for 1hr at RT.  After washing, recombinant wild-type or the 
indicated BiP mutant proteins (5 µM) were added and incubated for 1 hr at RT.  After 
washing, the amount of BiP that bound non-specifically to the wells was detected with a 
polyclonal anti-BiP antiserum, followed by donkey anti-rabbit Ig conjugated to alkaline 
phosphatase.  The signal was detected as described in Figure 4-4.
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